Ensembl_ID	Gene_symbol	logFC	FDR	Comparison	LncBook ID	Type	Conservation	miRNA	GWAS	nearest PC
ENSG00000251230	MIR3945HG	8.32175992415833	2.1313446441549095e-292	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0039050	integenic	Not conserved	hsa-miR-619-5p	Mean platelet volume,Mean reticulocyte volume,-	ACSL1
ENSG00000248323	LUCAT1	4.98285793112787	9.695989279718418e-217	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0043427	anti_sense	Q90	hsa-miR-619-5p,hsa-miR-4270,hsa-miR-4290,hsa-miR-5006-5p,hsa-miR-6089	Melanoma,Cervical carcinoma,Hematocrit,Red blood cell density measurement,Erythrocyte count,Body height,Uric acid measurement; Cystatin c measurement,Lean body mass,Hip geometry,Colorectal health,Adolescent idiopathic scoliosis,Colorectal cancer,-	ARRDC3
ENSG00000242048	PRKAG2-AS2	5.70178646115872	2.7510237550314794e-153	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0149841	anti_sense	Not conserved			GALNTL5
ENSG00000234883	MIR155HG	5.59094706064457	4.6774465159148496e-144	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0132382	anti_sense,sense	Q75	hsa-miR-6089,hsa-miR-8485	Neuropsychological test,Intelligence,Response to carboplatin,Nicotine dependence symptom count,Gout,Open-angle glaucoma,Triglyceride measurement,Erythrocyte count,Chronic lymphocytic leukemia,Cerebrospinal fluid biomarker measurement; Alpha synuclein measurement,Duchenne muscular dystrophy; Disease progression measurement,-,Amyloid plaque accumulation rate	JAM2
ENSG00000285744	ENSG00000285744	7.35295714176003	1.6147039615305798e-132	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0066417	integenic	Not conserved			ZC2HC1A
ENSG00000232956	SNHG15	3.09938539699896	2.82615629455928e-66	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0057702	anti_sense,sense	Q50	hsa-miR-4726-3p,hsa-miR-7107-5p	Body height,Diastolic blood pressure,-	MYO1G
ENSG00000260997	ENSG00000260997	5.42490002422447	1.53494463421971e-57	LPS_Whole_Cell_vs_Control_Whole_Cell	NA	NA	NA	NA	NA	MYO1G
ENSG00000253320	MAILR	4.27978161966064	1.00878606073476e-51	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0067488	integenic	Q50			ATP6V1C1
ENSG00000226137	BAIAP2-DT	-3.1699371440607	3.62822004717116e-51	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0119226	integenic	Not conserved	hsa-miR-3943	-	AATK
ENSG00000234456	MAGI2-AS3	4.84976942315197	8.78716809021755e-47	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0059170	anti_sense	Q75	hsa-miR-339-5p,hsa-miR-4447,hsa-miR-3960,hsa-miR-5001-3p,hsa-miR-6749-3p,hsa-miR-6786-5p,hsa-miR-8485	-	GNAI1
ENSG00000251136	RIPK2-DT	3.30780506817118	1.0209327488490999e-46	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0066822	integenic	Q50		Human papilloma virus infection; Oropharynx cancer,-	NBN
ENSG00000255521	CD44-DT	5.5260457614091	8.471658592734119e-42	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0083606	anti_sense	Q50		Response to vitamin,-	SLC1A2
ENSG00000235531	MSC-AS1	2.47670067313659	1.67883282837711e-40	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0066120	anti_sense	Not conserved		Lung carcinoma,Gout,Clinical treatment,Attention deficit hyperactivity disorder,Smoking behaviour measurement,Mental development measurement,Diastolic blood pressure,Forced expiratory volume; Response to bronchodilator,-	KCNB2
ENSG00000266709	ENSG00000266709	8.11876803733814	2.3058761434979998e-37	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0114719	intronic_sense	Q50			HS3ST3B1
ENSG00000225886	ENSG00000225886	6.08542393124757	7.99824458270809e-37	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0002013	integenic	Not conserved			FAM76A
ENSG00000186594	MIR22HG	1.96675003151942	2.18461881910604e-36	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0113835	anti_sense	Q90	hsa-miR-30d-3p,hsa-miR-30e-3p,hsa-miR-4268,hsa-miR-4433a-3p,hsa-miR-4468,hsa-miR-6735-5p	C-reactive protein measurement; Sex hormone-binding globulin measurement; Alkaline phosphatase measurement; Testosterone measurement; Calcium measurement; Urinary albumin to creatinine ratio; Serum albumin measurement; Triglyceride measurement,Calcium measurement; Blood protein measurement; Sex hormone-binding globulin measurement; Serum albumin measurement,-	TLCD2
ENSG00000289634	ENSG00000289634	7.4019629016903	8.99606545350165e-35	LPS_Whole_Cell_vs_Control_Whole_Cell	NA	NA	NA	NA	NA	SLCO4A1
ENSG00000259354	ENSG00000259354	3.86291972479598	1.30064738475216e-34	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0105653	intronic_antisense	Not conserved			C15orf48
ENSG00000224307	LINC02975	-5.79153591252524	2.91999605109066e-33	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0074715	integenic	Not conserved	hsa-miR-520a-5p,hsa-miR-4492,hsa-miR-4684-3p,hsa-miR-4748,hsa-miR-5693		NA
ENSG00000227502	MROCKI	9.85655355156216	2.55524433407201e-31	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0052921	integenic	Q50	hsa-miR-619-5p,hsa-miR-4505		HDAC2
ENSG00000271856	LINC01215	6.97513819748882	7.317811620086269e-31	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0027888	integenic	Q50			HHLA2
ENSG00000291109	CES1P1	6.11966657947069	1.27979557991989e-28	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0111659	integenic	Q50	hsa-miR-935		SLC6A2
ENSG00000231721	LINC-PINT	2.63367733566388	1.61138929885402e-27	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0150064	integenic	Q50			KLF14
ENSG00000261618	LINC02605	5.58521116397646	1.1610036002745099e-26	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0150243	integenic	Not conserved		Platelet-to-lymphocyte ratio; Lymphocyte count	ZC2HC1A
ENSG00000273472	ENSG00000273472	3.4495920734064	3.2334931558248296e-26	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0148201	integenic	Q50			ELMOD2
ENSG00000203446	SUGCT-AS1	2.36937080662017	8.97676960780523e-26	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0057426	anti_sense	Q90	hsa-miR-6089,hsa-miR-6824-3p	-	MPLKIP
ENSG00000260583	ENSG00000260583	9.53147617163466	1.596426984948e-25	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0147166	integenic	Not conserved			MRPL39
ENSG00000197536	IRF1-AS1	2.91906438712894	4.362927526494919e-25	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0044848	anti_sense,sense	Q50	hsa-miR-33b-5p,hsa-miR-4257,hsa-miR-4463,hsa-miR-6748-3p,hsa-miR-6803-5p	Fibrinogen measurement,Chronic obstructive pulmonary disease,Metabolite measurement,Apolipoprotein b measurement,Glycine measurement,Red blood cell distribution width,Neutrophil percentage of leukocytes,Ulcerative colitis; Diastolic blood pressure; Inflammatory bowel disease; Crohn's disease,Psoriasis; Inflammatory bowel disease; Ulcerative colitis; Ankylosing spondylitis; Crohn's disease; Adult onset asthma; Sclerosing cholangitis,Fibrinogen measurement; Sex hormone-binding globulin measurement,Urinary albumin to creatinine ratio,Diastolic blood pressure; Crohn's disease,Atopic asthma,Eosinophil count; Eosinophil percentage of leukocytes,Mean corpuscular hemoglobin,Nasal cavity polyp; Perceived unattractiveness to mosquitos measurement; Adult onset asthma,Serum metabolite measurement; Low density lipoprotein cholesterol measurement; Crohn's disease; Eczema; Systemic juvenile idiopathic arthritis, polyarticular juvenile idiopathic arthritis, rheumatoid factor negative, oligoarticular juvenile idiopathic arthritis; Rheumatoid arthritis; Aspartate aminotransferase measurement,Respiratory system disease; Adult onset asthma,Carotid plaque build,Low density lipoprotein cholesterol measurement,Chronic obstructive pulmonary disease; Smoking status measurement,Neutrophil count,Fibrinogen measurement; Lymphocyte count,Polycystic ovary syndrome,Fibrinogen measurement; Sex hormone-binding globulin measurement; Balding measurement,Neutrophil percentage of granulocytes; Eosinophil percentage of granulocytes; Mosquito bite reaction itch intensity measurement; Basophil count; Mosquito bite reaction size measurement; Eosinophil percentage of leukocytes; Eosinophil count,Mitochondrial dna measurement,Estrogen-receptor positive breast cancer; Breast carcinoma,Inhalant adrenergic use measurement,Cardiovascular disease,Eosinophil count,Diastolic blood pressure,Lymphocyte percentage of leukocytes,Total cholesterol measurement; Low density lipoprotein cholesterol measurement,Platelet count,Platelet crit,Psoriasis; Ulcerative colitis; Ankylosing spondylitis; Crohn's disease; Sclerosing cholangitis,Eczema; Allergic rhinitis,Fev/fec ratio,Autoimmune thyroid disease; Psoriasis; Common variable immunodeficiency; Mosquito bite reaction itch intensity measurement; Ulcerative colitis; Ankylosing spondylitis; Basophil count; Systemic lupus erythematosus; Crohn's disease; Mosquito bite reaction size measurement; Celiac disease; Autoimmune disease; Juvenile idiopathic arthritis,Psoriasis; Ulcerative colitis; Ankylosing spondylitis; Leukocyte count; Crohn's disease; Eosinophil percentage of leukocytes; Eosinophil count; Sclerosing cholangitis; Aspartate aminotransferase measurement,Hemoglobin a1 measurement,Reticulocyte count; Reticulocyte measurement,-	NA
ENSG00000247095	MIR210HG	3.68778334466944	2.60335386970218e-24	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0081992	anti_sense	Q50	hsa-miR-766-3p,hsa-miR-4707-5p,hsa-miR-5587-3p,hsa-miR-6735-5p,hsa-miR-6735-3p,hsa-miR-6858-5p,hsa-miR-7843-5p	Systemic lupus erythematosus,High density lipoprotein cholesterol measurement,-	LMNTD2
ENSG00000225964	NRIR	6.14123181956753	7.24439938245777e-23	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0012717	integenic	Q75		Depressive symptom measurement,-	CMPK2
ENSG00000180539	LINC02908	-4.56362652020178	3.0108843532868897e-22	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0075339	anti_sense	Q50	hsa-miR-210-5p,hsa-miR-619-5p,hsa-miR-4308,hsa-miR-4270,hsa-miR-6752-3p	Leukocyte count,Lymphocyte count,-	PAXX
ENSG00000230943	LINC02541	4.48895490058117	1.63023001563253e-21	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0052910	integenic	Not conserved			HDAC2
ENSG00000253123	ENSG00000253123	5.00764257384666	1.7963156147354998e-21	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0064558	integenic	Q90	hsa-miR-4483,hsa-miR-6743-3p,hsa-miR-7150,hsa-miR-8485	-	BRF2
ENSG00000178977	LINC00324	-3.00171407891442	7.83109844247574e-21	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0114404	overlap_sense,sense	Q75	hsa-miR-23a-5p,hsa-miR-1260b,hsa-miR-4526	Apolipoprotein a 1 measurement,Mitochondrial dna measurement,Panic disorder; Anxiety disorder,Diastolic blood pressure,-,Neuroticism measurement,Monocyte count	CTC1
ENSG00000277969	ENSG00000277969	2.48098755028057	8.79570238046384e-21	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0116179	integenic	Q75	hsa-miR-1247-5p,hsa-miR-3620-5p,hsa-miR-4505,hsa-miR-1587,hsa-miR-6721-5p		MLLT6
ENSG00000291156	ENSG00000291156	3.67699525904499	9.15989043163086e-21	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0000078	integenic	Not conserved		-	AGRN
ENSG00000276462	LINC03025	9.23645199854544	1.1120787999892799e-20	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0071581	integenic	Not conserved			FOXD4L6
ENSG00000234191	LINC01283	4.12948301747267	1.15149750090848e-19	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0137357	integenic	Q75			BCOR
ENSG00000288851	ENSG00000288851	1.55805510468185	4.3042947403573895e-19	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0048627	integenic	Q90	hsa-miR-4281,hsa-miR-4447,hsa-miR-4467,hsa-miR-4492		ACOT13
ENSG00000233834	MACC1-DT	6.25331523069312	2.38873226156329e-18	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0056475	anti_sense	Q50	hsa-miR-204-3p	Response to antineoplastic agent; Response to etoposide,-	ITGB8
ENSG00000250929	LINC01181	5.16426646648079	2.68351363142736e-17	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0067501	integenic	Q50		Small vessel stroke,Idiopathic osteonecrosis of the femoral head,Attention deficit hyperactivity disorder,Growth-regulated alpha protein measurement,Pelvic organ prolapse,-	BAALC
ENSG00000253522	MIR3142HG	4.05648969719129	7.565724867581531e-17	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0046249	integenic	Not conserved			PTTG1
ENSG00000236939	BAALC-AS2	9.09720385034869	7.64984064235207e-17	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0067505	anti_sense	Q50	hsa-miR-4447	Pelvic organ prolapse,Cognitive function measurement,Myopia,Late-onset alzheimers disease,Mathematical ability,Colorectal cancer; Breast carcinoma,Triglyceride measurement; Response to diuretic,Hemoglobin a1 measurement,-	AZIN1
ENSG00000214900	LINC01588	2.10835372232054	1.03997615361029e-16	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0101158	integenic	Q50			VCPKMT
ENSG00000267121	FMNL1-DT	1.97385386121192	6.244910304469879e-16	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0116830	anti_sense	Q75	hsa-miR-30b-3p,hsa-miR-185-3p,hsa-miR-619-5p,hsa-miR-675-5p,hsa-miR-5589-5p,hsa-miR-6089,hsa-miR-6791-5p,hsa-miR-7108-3p,hsa-miR-8485	Body fat distribution,White matter microstructure measurement,Body height,Thyroid stimulating hormone measurement,Bmi-adjusted hip circumference,-	SPATA32
ENSG00000259342	ENSG00000259342	5.29302435257989	8.70818007165824e-16	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0105649	anti_sense	Q75	hsa-miR-4505	-	GATM
ENSG00000237927	ENSG00000237927	4.46398612952955	3.2643836732026003e-15	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0054755	integenic	Not conserved	hsa-miR-183-5p,hsa-miR-5585-3p,hsa-miR-6089	Lipoprotein a measurement,Atrophic macular degeneration,-	SOD2
ENSG00000233621	ZC3H12A-DT	1.69465020307642	4.83774365053002e-15	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0002623	integenic	Not conserved			MEAF6
ENSG00000249502	MED28-DT	3.93914192829662	7.54561418819873e-15	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0033145	anti_sense	Q50	hsa-miR-619-5p,hsa-miR-4771	-	FAM184B
ENSG00000262580	ENSG00000262580	-1.72053815521225	5.10857352760228e-14	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0119173	anti_sense	Q50		Fasting blood glucose measurement,-,Psoriasis; Hirschsprung disease	SGSH
ENSG00000255921	ENSG00000255921	5.87597942787659	1.16659046147947e-13	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0089886	anti_sense	Not conserved	hsa-miR-6763-5p,hsa-miR-7847-3p	-	IRAG2
ENSG00000289942	ENSG00000289942	5.16687029002033	1.25130530071288e-13	LPS_Whole_Cell_vs_Control_Whole_Cell	NA	NA	NA	NA	NA	TMPRSS11E
ENSG00000286511	ENSG00000286511	6.15785530151958	1.49838139562004e-13	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0052591	integenic	Not conserved	hsa-miR-619-5p	Serum albumin measurement,Risk-taking behaviour,-	ARMC2
ENSG00000250116	RHOQ-AS1	2.8043276264149	1.86004569659003e-13	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0014691	anti_sense	Q75		-	PIGF
ENSG00000286646	MAP3K5-AS2	-2.4777428610786	2.08038957474273e-13	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0053719	anti_sense	Q50	hsa-miR-619-5p		PEX7
ENSG00000226281	ENSG00000226281	-2.84264580755828	2.70836549337355e-13	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0047836	integenic	Not conserved	hsa-miR-762,hsa-miR-5787		F13A1
ENSG00000251323	LINC02728	8.54872799436325	5.486812932876599e-13	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0085981	integenic	Q75	hsa-miR-4530	Creatinine measurement; Body height,Total blood protein measurement	GAB2
ENSG00000234608	MAPKAPK5-AS1	-1.552070723122	8.67249173782548e-13	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0094063	anti_sense	Q90	hsa-miR-210-5p,hsa-miR-619-5p,hsa-miR-3197,hsa-miR-3960,hsa-miR-7974	-	TMEM116
ENSG00000289880	ENSG00000289880	5.78322752830957	9.20494748170106e-13	LPS_Whole_Cell_vs_Control_Whole_Cell	NA	NA	NA	NA	NA	FAM177B
ENSG00000273812	LINC02970	2.77318643497354	1.4616738220463098e-12	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0131544	integenic	Q75	hsa-miR-1207-3p,hsa-miR-4505,hsa-miR-1587,hsa-miR-3064-5p,hsa-miR-7160-3p	-	GATA5
ENSG00000249738	ENSG00000249738	4.91277464452022	1.7893402455476998e-12	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0046209	integenic	Not conserved			UBLCP1
ENSG00000290041	ENSG00000290041	3.09449496798389	1.8485084396288298e-12	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0003215	anti_sense,sense	Q75	hsa-miR-619-5p	Soluble triggering receptor expressed on myeloid cells 2 measurement,Intraocular pressure measurement,-	BTBD19
ENSG00000272669	ENSG00000272669	2.76226979618589	2.39064410990624e-12	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0135442	anti_sense	Not conserved	hsa-miR-210-5p,hsa-miR-6763-3p		GTPBP1
ENSG00000284633	ENSG00000284633	6.47031079696745	6.4221983765733e-12	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0135492	anti_sense	Q50	hsa-miR-4463,hsa-miR-4776-5p,hsa-miR-6769b-5p	Fev/fec ratio,Ulcerative colitis; Crohn's disease; Inflammatory bowel disease,Psoriasis; Inflammatory bowel disease; Ulcerative colitis; Ankylosing spondylitis; Crohn's disease; Sclerosing cholangitis,Body weight,Platelet crit,Biliary liver cirrhosis,Hair colour measurement,Psoriasis; Ulcerative colitis; Ankylosing spondylitis; Crohn's disease; Sclerosing cholangitis,-	SYNGR1
ENSG00000271614	ATP2B1-AS1	2.93247733871183	1.3333139489567298e-11	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0092957	anti_sense	Q90	hsa-miR-619-5p,hsa-miR-4787-5p,hsa-miR-6749-3p,hsa-miR-6797-5p,hsa-miR-8485	Diastolic blood pressure,Risk-taking behaviour,Pulse pressure measurement; Mean arterial pressure; Alcohol drinking; Systolic blood pressure; Agents acting on the renin-angiotensin system use measurement,Hair colour measurement,Prostate carcinoma,Calcium measurement,Heel bone mineral density,Age at onset,Body mass index,Body height; Body mass index,Coronary artery disease,Body height,Chronotype measurement,Mean corpuscular volume,Magnesium measurement,Spine bone mineral density,Febrile seizure (within the age range of 3 months to 6 years); Mmr-related febrile seizures,Volumetric bone mineral density,Bone density,Heart rate,Biological sex,Systolic blood pressure,Creatinine measurement,C-reactive protein measurement,Pulse pressure measurement; Systolic blood pressure,Optic disc size measurement,Chronotype measurement; Heel bone mineral density,Diffusing capacity of the lung for carbon monoxide,Osteoarthritis, hip, osteoarthritis, knee,Diastolic blood pressure; Alcohol consumption measurement,Response to citalopram; Response to escitalopram; Triglyceride measurement,Ischemic stroke; Coronary artery disease,Diastolic blood pressure; Smoking status measurement; Systolic blood pressure,Body fat percentage,-	TMTC3
ENSG00000251442	LINC01094	-2.379089576395	1.3840217581486e-11	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0035402	integenic	Q50	hsa-miR-7150	Mean platelet volume,Total blood protein measurement; Serum albumin measurement; Aspartate aminotransferase measurement,Serum gamma-glutamyl transferase measurement,Monocyte count,Creatine kinase measurement; Serum non-albumin protein measurement,Protein measurement,Mean corpuscular volume; Mean corpuscular hemoglobin concentration,-	ANXA3
ENSG00000254287	ENSG00000254287	8.36850729441926	1.4399174055222498e-11	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0150387	anti_sense	Q50		-	ADAM2
ENSG00000289589	ENSG00000289589	4.77117840240351	2.0426070821064898e-11	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0008846	integenic	Not conserved	hsa-miR-619-5p,hsa-miR-7108-5p	Eosinophil count; Eosinophil percentage of leukocytes,Eosinophil count,Neuroimaging measurement; Cortical thickness; Brain measurement,-	STX6
ENSG00000273443	ENSG00000273443	6.46209025328936	6.01491334959402e-11	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0000079	integenic	Not conserved	hsa-miR-3615	-	RNF223
ENSG00000232618	HIVEP2-DT	8.22669277439487	6.3793719609165e-11	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0054003	anti_sense	Q50	hsa-miR-4279	Mean platelet volume,-	AIG1
ENSG00000263069	RNF213-AS1	3.28944663710029	6.42404871556226e-11	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0119191	anti_sense	Q50		-	NPTX1
ENSG00000225733	FGD5-AS1	-1.16639960047014	6.445868541243829e-11	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0024363	anti_sense	Q75	hsa-miR-6748-3p		MRPS25
ENSG00000262097	LINC02185	-3.56057244797508	8.8417499710514e-11	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0109713	integenic	Q50	hsa-miR-645,hsa-miR-4330,hsa-miR-4453	-	PARN
ENSG00000267519	MIR23AHG	1.46400374226174	2.3233484874892301e-10	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0124251	anti_sense	Q90		Waist-hip ratio,Neutrophil-to-lymphocyte ratio; Neutrophil percentage of leukocytes; Lymphocyte percentage of leukocytes,Leukocyte count; Lymphocyte count; Myeloid white cell count,Leukocyte count; Lymphocyte count,Lymphocyte count,Fev/fec ratio; Monocyte count,Leukocyte count,Myeloid white cell count; Lymphocyte count,Cortical thickness,-	BRME1
ENSG00000272512	ENSG00000272512	8.11974420683722	3.18517352009008e-10	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0000065	integenic	Not conserved		Apolipoprotein a 1 measurement,Parental longevity,-	HES4
ENSG00000224116	INHBA-AS1	6.26936742927836	4.86091257954839e-10	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0057482	integenic	Not conserved	hsa-miR-6124		SUGCT
ENSG00000185433	LINC00158	5.42148232489092	1.0395644802809e-9	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0132374	integenic	Not conserved			MRPL39
ENSG00000231964	ENSG00000231964	-2.43474798268733	1.2393580532533201e-9	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0077664	anti_sense	Not conserved	hsa-miR-520a-5p	Mean corpuscular volume,-	MARCHF8
ENSG00000287535	ENSG00000287535	6.10630421370159	1.3689222056616701e-9	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0064835	integenic	Not conserved	hsa-miR-744-5p,hsa-miR-6089		GPAT4
ENSG00000255750	ENSG00000255750	2.64718711723216	1.472908968645e-9	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0089971	anti_sense,sense	Q50		Bmi-adjusted waist circumference; Bmi-adjusted hip circumference; Bmi-adjusted waist-hip ratio,Hair morphology measurement,Leukocyte count; Lymphocyte count; Bmi-adjusted waist-hip ratio,Bmi-adjusted waist-hip ratio,Cup-to-disc ratio measurement,Balding measurement,Thrombin-antithrombin complex measurement,Bmi-adjusted waist circumference; Bmi-adjusted waist-hip ratio,Bmi-adjusted waist circumference,Alopecia; Androgenetic alopecia; Heel bone mineral density,Alopecia; Androgenetic alopecia; Balding measurement,Alopecia,Endometrial carcinoma,Mammographic density measurement,Bmi-adjusted waist circumference; Bmi-adjusted hip circumference; Physical activity measurement,Systolic blood pressure,High density lipoprotein cholesterol measurement,Bmi-adjusted hip circumference,Lymphocyte count,Bmi-adjusted waist circumference; Waist-hip ratio; Body fat percentage; Physical activity measurement; Reticulocyte count; High density lipoprotein cholesterol measurement; Bmi-adjusted waist-hip ratio; Triglyceride measurement; Reticulocyte measurement; Renal cell carcinoma,Heel bone mineral density,Serum alanine aminotransferase measurement; Waist-hip ratio,Sex hormone-binding globulin measurement; Heel bone mineral density; Bmi-adjusted hip circumference; Physical activity measurement; Bmi-adjusted waist-hip ratio; Triglyceride measurement,Triglyceride measurement,Sex hormone-binding globulin measurement,Body height,Cardiovascular disease,Alkaline phosphatase measurement; Total cholesterol measurement; Low density lipoprotein cholesterol measurement; Reticulocyte count; High density lipoprotein cholesterol measurement; Triglyceride measurement,Sex interaction measurement; Age at assessment; Bmi-adjusted waist-hip ratio,Bmi-adjusted waist circumference; Sex interaction measurement; Waist-hip ratio; Physical activity measurement; Bmi-adjusted hip circumference; Age at assessment; Smoking behavior; Bmi-adjusted waist-hip ratio,Bmi-adjusted hip circumference; Bmi-adjusted waist-hip ratio,Serum alanine aminotransferase measurement; High density lipoprotein cholesterol measurement; Bmi-adjusted waist-hip ratio; Physical activity measurement,Serum alanine aminotransferase measurement,Waist-hip ratio; Alkaline phosphatase measurement,Dense area measurement; Mammographic density measurement,Response to oxcarbazepine; Oxcarbazepine-induced hyponatremia; Carbamazepine-induced hyponatremia; Response to carbamazepine,-,Cognitive impairment measurement	ITPR2
ENSG00000271032	ENSG00000271032	4.77772750008543	2.15101549635766e-9	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0125561	anti_sense	Not conserved		Calcium measurement; Serum albumin measurement,Serum albumin measurement,-	ZNF792
ENSG00000178803	ADORA2A-AS1	4.1955464269086304	2.34785043477831e-9	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0134495	anti_sense	Q50	hsa-miR-370-3p,hsa-miR-6807-3p	Alcohol consumption measurement,Acne,Sodium measurement,Glucagon measurement,Coffee consumption measurement,Supramarginal gyrus volume measurement,Tea consumption measurement,Cups of coffee per day measurement,Serum gamma-glutamyl transferase measurement,Coffee consumption measurement; Tea consumption measurement,Alcohol use disorder measurement; Alcohol consumption measurement,-	GUCD1
ENSG00000215256	DHRS4-AS1	-1.87645375397585	2.35534154328551e-9	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0100084	integenic	Q50	hsa-miR-8089	-	NRL
ENSG00000284669	ENSG00000284669	6.03364751929299	3.85757212142062e-9	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0025266	anti_sense	Q90	hsa-miR-3620-5p,hsa-miR-4492,hsa-miR-1587,hsa-miR-6850-3p	Sex hormone-binding globulin measurement,Memory performance; Paragraph delayed recall measurement,-	TTC21A
ENSG00000250033	SLC7A11-AS1	4.38463447191079	5.9737466761669105e-9	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0037355	anti_sense	Q75	hsa-miR-6089	Body height,Neuroticism measurement,Neurotic disorder,Wellbeing measurement; Neuroticism measurement,Eosinophil count; Serum metabolite measurement; Depressive symptom measurement; Eosinophil percentage of leukocytes,Eosinophil count,Ccl2 measurement,Wellbeing measurement; Smoking behaviour measurement,-	NOCT
ENSG00000226824	ENSG00000226824	2.06298867527743	8.433203674644521e-9	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0058615	sense	Q50	hsa-miR-149-3p,hsa-miR-619-5p,hsa-miR-4441,hsa-miR-4667-3p,hsa-miR-6089,hsa-miR-6873-3p	-	RABGEF1
ENSG00000287252	ENSG00000287252	-4.38858577721385	1.17149104781921e-8	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0048904	integenic	Not conserved	hsa-miR-6089		H2AC13
ENSG00000256262	USP30-AS1	2.34584296398245	2.62425875185913e-8	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0093872	anti_sense	Not conserved	hsa-miR-4467,hsa-miR-3960	Platelet-to-lymphocyte ratio; Platelet count; Platelet crit,-	SVOP
ENSG00000287543	ENSG00000287543	3.32403359126195	2.88313286633459e-8	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0144564	anti_sense	Q50		Bmi-adjusted hip circumference,-	GOLGA6A
ENSG00000228318	ENSG00000228318	8.00186588369422	4.33304559303251e-8	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0133209	anti_sense,sense	Not conserved	hsa-miR-1268b,hsa-miR-6089	Serum alanine aminotransferase measurement,3-hydroxypropylmercapturic acid measurement,Atrial fibrillation; Diastolic blood pressure; Ventricular rate measurement; Diabetes mellitus; Heart failure; Cancer; Body mass index; Stroke; Total cholesterol measurement; Systolic blood pressure; Mortality; High density lipoprotein cholesterol measurement; Triglyceride measurement; Hematocrit; Glucose measurement; Coronary artery disease,-	TMPRSS2
ENSG00000240859	LINC03014	-1.94257752647061	4.3960113359412e-8	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0055497	integenic	Not conserved	hsa-miR-4447,hsa-miR-4478,hsa-miR-6784-5p,hsa-miR-6808-5p	-	FAM20C
ENSG00000214894	LINC00243	5.87622431095316	6.66239238920294e-8	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0049199	integenic	Not conserved	hsa-miR-619-5p,hsa-miR-6744-3p	Breast carcinoma,Mean platelet volume,Sleep duration,Cutaneous lupus erythematosus,Intelligence,Angina pectoris,Bmi-adjusted waist-hip ratio,Response to vaccine,Bmi-adjusted hip circumference,Reticulocyte count,Autoimmune thyroid disease; Bipolar disorder,Age-related macular degeneration,Reaction time measurement,Decreased fine motor function,17-hydroxyprogesterone measurement,Cytokine measurement,Protein measurement; Bmi-adjusted hip circumference,Bmi-adjusted hip circumference; Arterial stiffness measurement,Susceptibility to cold sores measurement,Susceptibility to plantar warts measurement,Susceptibility to chickenpox measurement,Susceptibility to shingles measurement,Autism spectrum disorder,Serum igg glycosylation measurement,Response to candesartan,Rosacea severity measurement,Cervical carcinoma,Eosinophil count,Glomerular filtration rate,Susceptibility to urinary tract infection measurement,Tonsillectomy risk measurement,Qrs amplitude; Qrs complex,Mosquito bite reaction size measurement; Mosquito bite reaction itch intensity measurement,-	IER3
ENSG00000288767	ENSG00000288767	5.11775981846604	1.70353122932494e-7	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0096284	integenic	Not conserved			RFC3
ENSG00000230438	SERPINB9P1	4.3270350564593	1.94341928582999e-7	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0047525	integenic	Not conserved			SERPINB9
ENSG00000217825	ENSG00000217825	7.64643619773646	2.23371240166825e-7	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0062556	integenic	Not conserved	hsa-miR-3065-3p		PAXIP1
ENSG00000271133	ITGB8-AS1	5.68362182863737	2.56457554560033e-7	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0056485	anti_sense	Q90	hsa-miR-5572,hsa-miR-7113-3p	-	MACC1
ENSG00000269959	SPACA6-AS1	5.7319788911253	3.14146746946614e-7	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0127249	anti_sense	Q75		Calcium measurement,Body height,-	HAS1
ENSG00000291114	SIGLEC17P	-2.10746863838383	3.56936196070431e-7	LPS_Whole_Cell_vs_Control_Whole_Cell	NA	NA	NA	NA	NA	SIGLEC7
ENSG00000281103	TRG-AS1	1.1973896436342	3.78069709573618e-7	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0057335	integenic	Not conserved			STARD3NL
ENSG00000273033	LINC02035	-1.16645656117104	5.93223389894581e-7	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0028514	integenic	Q75		Protein measurement,-	SLC49A4
ENSG00000233058	ATP13A3-DT	2.19784298702766	6.81545945285109e-7	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0031735	anti_sense	Q50	hsa-miR-619-5p,hsa-miR-4294	Lean mass-adjusted fat body mass; Femoral neck bone mineral density,3-hydroxypropylmercapturic acid measurement,-	FAM43A
ENSG00000224660	SH3BP5-AS1	1.19878090519665	7.6209028812915e-7	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0024394	anti_sense	Q90		-	CAPN7
ENSG00000255197	ENSG00000255197	-1.22367652209519	8.18138028317723e-7	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0143174	anti_sense	Q90		Alcohol consumption measurement	SPI1
ENSG00000276649	ENSG00000276649	2.50581537096235	8.48055823059446e-7	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0128155	anti_sense	Q75	hsa-miR-361-3p,hsa-miR-762,hsa-miR-4710,hsa-miR-5008-5p,hsa-miR-6845-3p	Uridine diphosphate galactose measurement; Uridine diphosphate glucose measurement,-	PDYN
ENSG00000225194	LINC00092	-2.27769864181289	8.92146240335273e-7	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0073016	anti_sense	Q75	hsa-miR-1268b	Lymphocyte count,-	HSD17B3
ENSG00000233016	SNHG7	-1.35990850647708	9.06143829811692e-7	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0075291	anti_sense	Q90	hsa-miR-6089,hsa-miR-6829-3p	Body height,-	NA
ENSG00000286248	ENSG00000286248	2.38828182056903	1.08700486549221e-6	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0094569	anti_sense	Not conserved	hsa-miR-1268b	Interleukin-8 measurement; C-reactive protein measurement; Chronic obstructive pulmonary disease,C-reactive protein measurement,C-reactive protein measurement; Serum gamma-glutamyl transferase measurement,-	CAMKK2
ENSG00000272625	ENSG00000272625	2.9284995389417	1.37431121963288e-6	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0119665	anti_sense,sense	Q75	hsa-miR-4520-5p	-	EMILIN2
ENSG00000234771	SLC25A25-AS1	-2.5428216841901	1.72069690618246e-6	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0074573	anti_sense	Q90	hsa-miR-328-5p,hsa-miR-1228-5p,hsa-miR-3714,hsa-miR-2392,hsa-miR-6803-5p	-	PTGES2
ENSG00000244586	WNT5A-AS1	5.49026671589864	1.93226031176361e-6	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0147531	anti_sense	Q90	hsa-miR-7108-3p	-	CACNA2D3
ENSG00000274213	ENSG00000274213	2.86661577095804	2.0599332874673e-6	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0117605	integenic	Not conserved	hsa-miR-500b-3p	-	DGKE
ENSG00000261644	CYLD-AS1	1.98467462353907	2.11417285931514e-6	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0111361	anti_sense	Q50	hsa-miR-6089,hsa-miR-8485	Psoriasis; Inflammatory bowel disease; Ulcerative colitis; Ankylosing spondylitis; Crohn's disease; Sclerosing cholangitis,Psoriasis; Ulcerative colitis; Ankylosing spondylitis; Crohn's disease; Sclerosing cholangitis,-	SNX20
ENSG00000291233	ENSG00000291233	2.1179585775143	2.12792995490371e-6	LPS_Whole_Cell_vs_Control_Whole_Cell	NA	NA	NA	NA	NA	NBPF9
ENSG00000285906	ENSG00000285906	1.54951494386704	2.23785456131307e-6	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0024144	anti_sense	Q50	hsa-miR-363-5p,hsa-miR-619-5p,hsa-miR-1233-5p,hsa-miR-1303,hsa-miR-4266,hsa-miR-6089	Bmi-adjusted hip circumference,Blood urea nitrogen measurement,Appendicular lean mass,Pulse pressure measurement; Diastolic blood pressure; Systolic blood pressure,Lean body mass; Bone measurement; Fat body mass	VGLL4
ENSG00000223923	TNS1-AS1	4.70459281880197	2.26971047573744e-6	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0022218	anti_sense	Q50	hsa-miR-30b-3p,hsa-miR-4265,hsa-miR-6873-3p	Cognitive decline measurement,-	RUFY4
ENSG00000235897	TM4SF19-AS1	1.76055300288727	2.47303227870364e-6	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0031920	anti_sense	Q75	hsa-miR-6809-3p,hsa-miR-8485	C-reactive protein measurement,Mean corpuscular hemoglobin,-	SLC51A
ENSG00000230647	ENSG00000230647	7.43751251209673	2.80133030102285e-6	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0145008	integenic	Q75	hsa-miR-619-5p	Heel bone mineral density,-	HS3ST3B1
ENSG00000223901	ENSG00000223901	4.0736322648663	3.22762503434344e-6	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0133720	anti_sense	Q50		-	YBEY
ENSG00000256234	ITPR2-AS1	1.81352570284663	4.19504930098181e-6	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0089971	anti_sense,sense	Q50		Bmi-adjusted waist circumference; Bmi-adjusted hip circumference; Bmi-adjusted waist-hip ratio,Hair morphology measurement,Leukocyte count; Lymphocyte count; Bmi-adjusted waist-hip ratio,Bmi-adjusted waist-hip ratio,Cup-to-disc ratio measurement,Balding measurement,Thrombin-antithrombin complex measurement,Bmi-adjusted waist circumference; Bmi-adjusted waist-hip ratio,Bmi-adjusted waist circumference,Alopecia; Androgenetic alopecia; Heel bone mineral density,Alopecia; Androgenetic alopecia; Balding measurement,Alopecia,Endometrial carcinoma,Mammographic density measurement,Bmi-adjusted waist circumference; Bmi-adjusted hip circumference; Physical activity measurement,Systolic blood pressure,High density lipoprotein cholesterol measurement,Bmi-adjusted hip circumference,Lymphocyte count,Bmi-adjusted waist circumference; Waist-hip ratio; Body fat percentage; Physical activity measurement; Reticulocyte count; High density lipoprotein cholesterol measurement; Bmi-adjusted waist-hip ratio; Triglyceride measurement; Reticulocyte measurement; Renal cell carcinoma,Heel bone mineral density,Serum alanine aminotransferase measurement; Waist-hip ratio,Sex hormone-binding globulin measurement; Heel bone mineral density; Bmi-adjusted hip circumference; Physical activity measurement; Bmi-adjusted waist-hip ratio; Triglyceride measurement,Triglyceride measurement,Sex hormone-binding globulin measurement,Body height,Cardiovascular disease,Alkaline phosphatase measurement; Total cholesterol measurement; Low density lipoprotein cholesterol measurement; Reticulocyte count; High density lipoprotein cholesterol measurement; Triglyceride measurement,Sex interaction measurement; Age at assessment; Bmi-adjusted waist-hip ratio,Bmi-adjusted waist circumference; Sex interaction measurement; Waist-hip ratio; Physical activity measurement; Bmi-adjusted hip circumference; Age at assessment; Smoking behavior; Bmi-adjusted waist-hip ratio,Bmi-adjusted hip circumference; Bmi-adjusted waist-hip ratio,Serum alanine aminotransferase measurement; High density lipoprotein cholesterol measurement; Bmi-adjusted waist-hip ratio; Physical activity measurement,Serum alanine aminotransferase measurement,Waist-hip ratio; Alkaline phosphatase measurement,Dense area measurement; Mammographic density measurement,Response to oxcarbazepine; Oxcarbazepine-induced hyponatremia; Carbamazepine-induced hyponatremia; Response to carbamazepine,-,Cognitive impairment measurement	ITPR2
ENSG00000221949	LINC01465	2.48190852178929	4.83421258387743e-6	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0143651	integenic	Q75	hsa-miR-4447	-	PPM1H
ENSG00000244879	GABPB1-AS1	-1.26012725072584	5.01166340555683e-6	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0105872	anti_sense,sense	Q90	hsa-miR-619-5p,hsa-miR-4505	Superior frontal gyrus volume measurement,Adolescent idiopathic scoliosis,Testosterone measurement,Platelet crit,Breast carcinoma,Fev/fec ratio,Body height,Blood phosphate measurement,-	USP8
ENSG00000289485	ENSG00000289485	5.39003331707732	5.75792319823588e-6	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0116006	anti_sense	Not conserved		C-c motif chemokine 3 measurement,Blood protein measurement,Clopidogrel metabolite measurement,Visual perception measurement,Protein measurement,Refractive error; Ccl4 measurement; Blood protein measurement; Age at onset; Myopia	TBC1D3B
ENSG00000248727	LINC01948	-2.56285270887731	6.85251025762855e-6	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0041950	integenic	Not conserved		Macula measurement,High density lipoprotein cholesterol measurement,Bmi-adjusted waist-hip ratio,Bmi-adjusted waist circumference,Glucose measurement,Glaucoma; Open-angle glaucoma,Bmi-adjusted waist circumference; Bmi-adjusted waist-hip ratio,-	ANKRD55
ENSG00000212694	LINC01089	-1.43744151973831	8.97609661705569e-6	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0094605	anti_sense,sense	Q90	hsa-miR-525-3p,hsa-miR-524-3p,hsa-miR-762,hsa-miR-3692-5p,hsa-miR-4433a-3p,hsa-miR-4472,hsa-miR-3155b,hsa-miR-4787-5p,hsa-miR-5581-5p,hsa-miR-5787,hsa-miR-6763-5p,hsa-miR-6803-5p,hsa-miR-4433b-3p	Leukocyte count; Neutrophil count; Myeloid white cell count; Platelet crit,Mean platelet volume,Eosinophil count,-	RHOF
ENSG00000247828	TMEM161B-DT	-1.46813855516418	9.81817059552268e-6	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0043363	integenic	Q90	hsa-miR-4438		RASA1
ENSG00000286153	ENSG00000286153	2.04716895739339	1.22423290366305e-5	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0132875	anti_sense	Not conserved		Erythrocyte count; Response to vaccine; Mean corpuscular hemoglobin; Cognitive decline measurement; Monocyte percentage of leukocytes,Balding measurement,Alopecia,Eosinophil count,Monocyte count,-	CLIC6
ENSG00000289526	ENSG00000289526	2.91641611371267	1.45625521695079e-5	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0083600	anti_sense	Q50		Covid-19,Uterine fibroid,Heel bone mineral density,Systemic lupus erythematosus,Systemic lupus erythematosus; Heel bone mineral density,Uterine fibroid; Bone density,Hip bone mineral density,Sex hormone-binding globulin measurement,Triglyceride measurement; Response to hydrochlorothiazide,-	APIP
ENSG00000273129	PACERR	5.54081708726335	1.62783610504658e-5	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0009103	integenic	Not conserved	hsa-miR-3960	-	PLA2G4A
ENSG00000275294	LINC02340	7.18190857653902	1.72925857390422e-5	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0095919	integenic	Q50		Creatinine measurement; Serum gamma-glutamyl transferase measurement; Glomerular filtration rate,Glomerular filtration rate,Aspartate aminotransferase measurement,Serum gamma-glutamyl transferase measurement,Creatinine measurement,-	USP12
ENSG00000251194	ENSG00000251194	2.89907211898556	1.75589389961724e-5	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0083609	sense	Q50			CD44
ENSG00000198496	NBR2	-1.85849328964242	1.76374632602804e-5	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0116616	anti_sense	Not conserved	hsa-miR-619-5p,hsa-miR-6089	Age at menopause,Neutrophil count,-	NBR1
ENSG00000289039	ENSG00000289039	3.97116056312833	1.87759657611261e-5	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0081853	integenic	Not conserved	hsa-miR-1225-3p,hsa-miR-4492	Microglial activation measurement	ADGRA1
ENSG00000290862	NMRAL2P	1.66612634834213	2.00893732560927e-5	LPS_Whole_Cell_vs_Control_Whole_Cell	NA	NA	NA	NA	NA	SENP2
ENSG00000215458	AATBC	-2.46490873414373	2.03913878920721e-5	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0133454	anti_sense	Not conserved	hsa-miR-6089	-	CSTB
ENSG00000254837	LIPT2-AS1	-3.40762835253659	2.08862058566984e-5	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0143021	sense	Not conserved			POLD3
ENSG00000205930	C21orf62-AS1	-7.26548168388097	2.27776508220396e-5	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0132731	integenic	Q90		Tea consumption measurement,-	OLIG2
ENSG00000291033	TXLNGY	-1.40148670667395	2.51693987813337e-5	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0141378	integenic	Not conserved	hsa-miR-363-5p		EIF1AY
ENSG00000250274	ENSG00000250274	5.22090643655958	2.65057085103839e-5	LPS_Whole_Cell_vs_Control_Whole_Cell	NA	NA	NA	NA	NA	LCP2
ENSG00000287733	ENSG00000287733	1.88031186277342	2.66508511871339e-5	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0061536	integenic	Not conserved	hsa-miR-4761-3p	Monocyte count	TMEM140
ENSG00000231233	CFAP58-DT	2.27889646419278	2.83825710221933e-5	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0080427	integenic	Q50			ITPRIP
ENSG00000205181	LINC00654	-1.70195587898057	2.96411229664198e-5	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0128395	integenic	Q50	hsa-miR-30b-3p,hsa-miR-4505,hsa-miR-5004-5p,hsa-miR-6089,hsa-miR-6500-5p,hsa-miR-6510-5p,hsa-miR-6776-5p,hsa-miR-7110-3p,hsa-miR-7150	Microglial activation measurement,Apolipoprotein b measurement,-	GPCPD1
ENSG00000278330	ENSG00000278330	-3.33386730730741	2.98869006816112e-5	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0122607	anti_sense	Not conserved		-	GALR1
ENSG00000278546	ENSG00000278546	5.36341709919965	3.12265386924947e-5	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0115707	integenic	Q90		Heel bone mineral density,Body height,Human papilloma virus infection,Myocardial infarction,Systolic blood pressure,Balding measurement,Hippocampal volume,Pulse pressure measurement,Prostate carcinoma,Eosinophil count,Diet measurement; Body mass index,Covid-19; Pneumonia,Coronary artery disease,-	RAB11FIP4
ENSG00000231858	STAT4-AS1	7.07721565198807	3.16478497388637e-5	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0021145	anti_sense	Q75	hsa-miR-3666	-	GLS
ENSG00000258667	HIF1A-AS3	3.58443731232271	3.84535064524866e-5	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0101781	anti_sense	Q50	hsa-miR-619-5p	-	TMEM30B
ENSG00000287188	ENSG00000287188	6.95795797525272	5.39144434610636e-5	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0038414	anti_sense	Q50		-	DDX60
ENSG00000268812	LIF-AS2	6.99773144321934	5.61757954132551e-5	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0134872	anti_sense	Q90	hsa-miR-3178	-	HORMAD2
ENSG00000231811	ENSG00000231811	2.51869816630049	5.63918780723685e-5	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0047724	integenic	Not conserved	hsa-miR-4447		ECI2
ENSG00000269834	ZNF528-AS1	-2.35823652602291	5.98034526150197e-5	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0127314	integenic	Not conserved	hsa-miR-619-5p,hsa-miR-1268b	-	ZNF83
ENSG00000270069	MIR222HG	2.41316986723598	5.98565108855469e-5	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0137593	integenic	Q90	hsa-miR-574-5p,hsa-miR-1343-3p,hsa-miR-6803-5p,hsa-miR-6873-3p,hsa-miR-9899	Body height; Inguinal hernia; Body weight	DIPK2B
ENSG00000242474	LINC03015	-1.94954404803536	6.13290240189096e-5	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0055495	integenic	Not conserved		-	PDGFA
ENSG00000232098	ZNF584-DT	-2.51229586232587	6.23477723546171e-5	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0127962	anti_sense	Not conserved		Mean platelet volume,-	ZNF837
ENSG00000273124	ENSG00000273124	6.87219481730066	6.27930027335967e-5	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0079637	integenic	Q50	hsa-miR-4650-5p,hsa-miR-6132,hsa-miR-6763-5p	Fibroblast growth factor basic measurement,-	ANKRD1
ENSG00000215039	CD27-AS1	-1.35153462838611	6.54912168300692e-5	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0088857	anti_sense	Q50	hsa-miR-642a-5p,hsa-miR-4292,hsa-miR-3620-5p,hsa-miR-4447,hsa-miR-1587,hsa-miR-6514-3p,hsa-miR-6752-3p,hsa-miR-6784-5p,hsa-miR-6890-3p	-	VAMP1
ENSG00000236700	LINC01010	1.32676726360871	6.56890670593093e-5	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0053623	integenic	Q50	hsa-miR-619-5p,hsa-miR-4267,hsa-miR-4430,hsa-miR-6089	Dental caries,-	TBPL1
ENSG00000245937	SLC12A2-DT	-1.40864618347104	6.75914808686732e-5	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0044716	anti_sense	Q50	hsa-miR-140-3p,hsa-miR-4691-3p	Facial hair thickness measurement,Red blood cell distribution width; Apolipoprotein a 1 measurement; Myeloid white cell count; High density lipoprotein cholesterol measurement; Bmi-adjusted waist-hip ratio; Skin and soft tissue staphylococcus aureus infection,Serum alanine aminotransferase measurement; Sex hormone-binding globulin measurement; Low density lipoprotein triglyceride measurement; Body fat percentage; Waist-hip ratio; Total blood protein measurement; High density lipoprotein cholesterol measurement; Appendicular lean mass; Vital capacity; Aspartate aminotransferase measurement,Lean body mass,Systolic blood pressure,Varicose veins; Sex hormone-binding globulin measurement; Fev/fec ratio; High density lipoprotein cholesterol measurement; Serum albumin measurement,Red blood cell distribution width,Body height,Lymphocyte percentage of leukocytes; Lymphocyte count; Bmi-adjusted waist circumference; Nicotine dependence symptom count; Neutrophil percentage of leukocytes; Platelet-to-lymphocyte ratio,Serum alanine aminotransferase measurement; Appendicular lean mass,Bmi-adjusted waist-hip ratio,Body fat distribution; Lymphocyte count; Red blood cell distribution width,Calcium measurement; Sex hormone-binding globulin measurement; Serum albumin measurement; Red blood cell distribution width,Breast carcinoma,-	FBN2
ENSG00000289080	ENSG00000289080	-7.15737110133073	7.07350105427267e-5	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0110565	integenic	Not conserved	hsa-miR-1228-5p,hsa-miR-4492	Lymphocyte count,-	RABEP2
ENSG00000226239	ENSG00000226239	7.22186246352815	7.30729342653644e-5	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0129532	anti_sense	Q50		Cystatin c measurement,Cognitive decline measurement,-	PDRG1
ENSG00000179428	IL6-AS1	6.96438638445648	7.84533426318271e-5	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0056610	anti_sense,sense	Q50		Platelet count; Aspartate aminotransferase measurement,Cerebrospinal fluid clusterin measurement,C-reactive protein measurement,Leukocyte count,C-reactive protein measurement; Mean corpuscular hemoglobin,Serum albumin measurement,Unipolar depression,Lymphocyte percentage of leukocytes,Serum alanine aminotransferase measurement,Parental genotype effect measurement; Birth weight,Leukocyte count; C-reactive protein measurement; Lymphocyte count,Lymphocyte count,Lung carcinoma,Mean corpuscular hemoglobin,Albumin:globulin ratio measurement; Serum non-albumin protein measurement,Platelet count,Bilirubin measurement,Leukocyte count; Neutrophil count; Myeloid white cell count; 3-hydroxyphenylacetic acid measurement,Serum albumin measurement; C-reactive protein measurement; Body height,Tonsillectomy risk measurement,Longevity; Takayasu arteritis,Eosinophil count,Pulse pressure measurement,Systemic lupus erythematosus,Serum non-albumin protein measurement,Aortic stenosis; Aortic valve calcification,Pulse pressure measurement; Cerebrospinal fluid clusterin measurement,-	STEAP1B
ENSG00000265206	MIR142HG	1.12748185098993	8.27008451337321e-5	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0117712	integenic	Q75	hsa-miR-4313,hsa-miR-4722-5p,hsa-miR-6780a-3p	Platelet crit; Late-onset alzheimers disease; Platelet count; Monocyte count; Family history of alzheimer’s disease,Leukocyte count,-	TSPOAP1
ENSG00000196951	SCOC-AS1	-3.01637177583727	8.28651336629758e-5	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0037486	anti_sense	Not conserved	hsa-miR-370-3p		CLGN
ENSG00000291097	HLA-L	2.38412777720308	9.39323758512389e-5	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0049134	integenic	Not conserved			TRIM39
ENSG00000262370	ENSG00000262370	-1.53093516617047	1.0048332124459e-4	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0109115	anti_sense	Not conserved	hsa-miR-4329	Body height,-	ZSCAN10
ENSG00000235823	OLMALINC	-1.24188322185594	1.0442557147918e-4	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0080102	sense	Q50	hsa-miR-378a-5p,hsa-miR-619-5p,hsa-miR-6089	Alkaline phosphatase measurement,-	SCD
ENSG00000223768	LINC00205	-1.16286782878264	1.0517728257904e-4	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0133618	integenic	Q50	hsa-miR-92b-5p,hsa-miR-619-5p,hsa-miR-1205,hsa-miR-3692-5p,hsa-miR-3934-5p,hsa-miR-4472,hsa-miR-4505,hsa-miR-6751-3p,hsa-miR-6803-5p	Systemic lupus erythematosus,Bmi-adjusted waist-hip ratio,Bmi-adjusted waist circumference; Bmi-adjusted waist-hip ratio,Bmi-adjusted waist circumference,-	ADARB1
ENSG00000224950	ENSG00000224950	1.52091597014135	1.0548267695872e-4	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0006329	sense	Q50	hsa-miR-619-5p,hsa-miR-670-5p,hsa-miR-920,hsa-miR-3160-5p,hsa-miR-4286,hsa-miR-4447,hsa-miR-4722-5p,hsa-miR-6089,hsa-miR-6132,hsa-miR-6776-5p	Covid-19,Diastolic blood pressure,Cystatin c measurement,Leukocyte count; Neutrophil count,Creatinine measurement,Systemic lupus erythematosus,Primary biliary cirrhosis,Response to sulfasalazine; Drug-induced agranulocytosis,Stressful life event measurement; Depressive symptom measurement,-	CD58
ENSG00000249173	LINC01093	3.08965572723045	1.0588343701395e-4	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0039055	integenic	Q50	hsa-miR-619-5p,hsa-miR-4505,hsa-miR-6808-5p,hsa-miR-6769b-5p		ACSL1
ENSG00000286989	ENSG00000286989	-3.45055363112261	1.0787195211595e-4	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0000179	overlap_antisense	Q50	hsa-miR-338-3p,hsa-miR-4292,hsa-miR-4472,hsa-miR-1343-3p,hsa-miR-5572,hsa-miR-5587-3p,hsa-miR-6511b-3p,hsa-miR-6754-5p,hsa-miR-6803-5p,hsa-miR-6804-3p,hsa-miR-6890-3p	Serum alanine aminotransferase measurement; Sex hormone-binding globulin measurement; Low density lipoprotein triglyceride measurement; Body fat percentage; High density lipoprotein cholesterol measurement; Aspartate aminotransferase measurement,-	MIB2
ENSG00000235314	LINC00957	-2.80076549614308	1.325374126284e-4	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0057613	integenic	Not conserved	hsa-miR-619-5p,hsa-miR-4466,hsa-miR-4505,hsa-miR-5585-3p,hsa-miR-6747-3p,hsa-miR-6784-5p	-	DBNL
ENSG00000255517	DPP3-DT	-2.14049018134148	1.3401885033892e-4	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0085026	anti_sense	Q75	hsa-miR-619-5p,hsa-miR-4763-3p,hsa-miR-2467-3p,hsa-miR-6085	Hematocrit,-	MRPL11
ENSG00000228013	IL6R-AS1	3.74003322300683	1.3691868984881e-4	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0007394	anti_sense	Q75	hsa-miR-4710,hsa-miR-6736-5p	C-reactive protein measurement,C-reactive protein measurement; Serum non-albumin protein measurement,Albumin:globulin ratio measurement,Total blood protein measurement,Serum non-albumin protein measurement,Systemic juvenile idiopathic arthritis, polyarticular juvenile idiopathic arthritis, rheumatoid factor negative, oligoarticular juvenile idiopathic arthritis,-	SHE
ENSG00000267296	CEBPA-DT	-2.95681334329581	1.3785928359693e-4	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0125425	integenic	Q50	hsa-miR-1303,hsa-miR-6764-5p	Bmi-adjusted waist circumference,Reticulocyte count; Reticulocyte measurement,-	CEBPG
ENSG00000260267	ENSG00000260267	2.10297694664849	1.4207316645611e-4	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0110866	anti_sense,sense	Q50	hsa-miR-298	Pyruvate measurement,Mean corpuscular volume,-	ZNF843
ENSG00000247708	STX18-AS1	1.58095395837566	1.5137392418974e-4	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0032553	integenic	Q50			MSX1
ENSG00000274536	MIR223HG	-1.57235151964247	1.624417380282e-4	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0138297	anti_sense	Q50	hsa-miR-331-3p	Balding measurement,Eosinophil count,Alopecia,Mean platelet volume; Platelet count,Eosinophil percentage of leukocytes	HEPH
ENSG00000289977	ENSG00000289977	-3.59955341696437	1.7219971852246e-4	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0114255	integenic	Not conserved			ACADVL
ENSG00000256292	LINC02376	6.75493276665889	1.794371072661e-4	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0094989	integenic	Not conserved	hsa-miR-4274,hsa-miR-6769b-3p	White matter hyperintensity measurement,Response to antidepressant,-	SLC15A4
ENSG00000289047	ENSG00000289047	-1.31535624331211	1.8462497690384e-4	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0049461	integenic	Not conserved	hsa-miR-619-5p,hsa-miR-4447	Manic or hypomanic episode,Lumbar disc degeneration	PSMB9
ENSG00000289268	ENSG00000289268	-1.92777622535439	2.0705333537031e-4	LPS_Whole_Cell_vs_Control_Whole_Cell	NA	NA	NA	NA	NA	FADS1
ENSG00000181577	LINC03040	3.65741778650863	2.311468045071e-4	LPS_Whole_Cell_vs_Control_Whole_Cell	NA	NA	NA	NA	NA	TMEM63B
ENSG00000267607	ICAM4-AS1	3.35572654530871	2.4114772153151e-4	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0123921	anti_sense	Q50	hsa-miR-361-3p,hsa-miR-4472,hsa-miR-4632-3p,hsa-miR-6803-5p,hsa-miR-7111-3p	Icam-1 measurement,Covid-19; Blood protein measurement,Icam-1 measurement; Adhesion molecule measurement,-,Protein measurement,Blood protein measurement; Sex hormone-binding globulin measurement	ZGLP1
ENSG00000224078	SNHG14	-1.38693760424189	2.4282452523429e-4	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0104546	anti_sense,sense	Q75	hsa-miR-30b-3p,hsa-miR-188-3p,hsa-miR-370-3p,hsa-miR-574-5p,hsa-miR-619-5p,hsa-miR-3176,hsa-miR-4268,hsa-miR-4430,hsa-miR-4478,hsa-miR-4492,hsa-miR-3064-3p,hsa-miR-4755-3p,hsa-miR-5193,hsa-miR-5693,hsa-miR-6845-5p,hsa-miR-6858-5p,hsa-miR-7109-5p	Panic disorder,Blood osmolality measurement,Neuroticism measurement,Myopia,Bone density,Inflammatory biomarker measurement; Ykl40 measurement,-	SNRPN
ENSG00000240057	NEPRO-AS1	3.10826359786922	2.5605900961112e-4	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0028082	integenic	Q90	hsa-miR-296-3p	Telomere length,Myopia,Body height	GTPBP8
ENSG00000291122	CASTOR3P	-1.87731720007186	2.6820825606579e-4	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0150011	sense	Not conserved	hsa-miR-125a-3p		GPC2
ENSG00000268947	ENSG00000268947	-3.86736879564522	2.7835448127594e-4	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0125591	sense	Not conserved	hsa-miR-619-5p,hsa-miR-6089		LSR
ENSG00000281404	LINC01176	1.24929439751384	2.7876143338047e-4	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0149630	sense	Not conserved			NA
ENSG00000232063	ENSG00000232063	-2.87094345509959	2.841227308734e-4	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0072909	integenic	Not conserved	hsa-miR-7108-3p	-	MFSD14B
ENSG00000286786	ENSG00000286786	3.48336759329546	2.8953421980732e-4	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0105124	anti_sense	Q50	hsa-miR-5787,hsa-miR-6873-3p	-	FAM98B
ENSG00000271855	ENSG00000271855	3.88513558823567	2.9754009923651e-4	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0012908	anti_sense	Q50	hsa-miR-619-5p,hsa-miR-1237-5p,hsa-miR-4508,hsa-miR-1587,hsa-miR-6089,hsa-miR-6724-5p	Waist-hip ratio; Birth weight; Bmi-adjusted waist-hip ratio; Parental genotype effect measurement,Waist-hip ratio,Heart rate,-	IAH1
ENSG00000287937	ENSG00000287937	4.31969246185272	3.0093833821662e-4	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0018002	integenic	Not conserved	hsa-miR-6769b-5p	Corneal endothelial cell measurement; Interleukin-1 beta measurement,Interleukin-1 beta measurement,Behcet's syndrome,-	IL1B
ENSG00000259673	IQCH-AS1	-2.53716494835098	3.3979022553848e-4	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0106756	anti_sense	Q90	hsa-miR-30b-3p,hsa-miR-615-5p,hsa-miR-4478,hsa-miR-6089,hsa-miR-6762-3p,hsa-miR-6849-3p,hsa-miR-6769b-3p,hsa-miR-7703	Serum gamma-glutamyl transferase measurement,Left ventricular diastolic function measurement,Bmi-adjusted hip circumference,Bmi-adjusted waist circumference,Waist-hip ratio,Bipolar disorder,Bone density,Body mass index,Age at menarche,Erythrocyte count,Body fat percentage,Neuroticism measurement,Response to peginterferon alfa-2a,Risk-taking behaviour,Insomnia measurement,-	AAGAB
ENSG00000231365	WARS2-AS1	-1.45889174433169	3.4055382971137e-4	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0006479	integenic	Not conserved			HAO2
ENSG00000277782	ENSG00000277782	2.68978640795216	3.7092160853339e-4	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0107630	anti_sense	Q90	hsa-miR-5787	-	MESD
ENSG00000177406	NINJ2-AS1	-1.37599525836016	3.7567260955219e-4	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0088498	anti_sense	Q50	hsa-miR-6809-3p	Platelet component distribution width,Mean platelet volume; Lymphocyte count; Platelet crit; Neutrophil percentage of leukocytes; Platelet count; Monocyte count,Soluble triggering receptor expressed on myeloid cells 2 measurement,Monocyte percentage of leukocytes,Monocyte count,Granulocyte percentage of myeloid white cells; Monocyte percentage of leukocytes,-	B4GALNT3
ENSG00000231890	DARS1-AS1	3.00972031961052	4.3993618105376e-4	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0019085	anti_sense	Q90	hsa-miR-331-3p,hsa-miR-1227-5p,hsa-miR-4292,hsa-miR-550b-2-5p,hsa-miR-4492,hsa-miR-4701-5p	Leukocyte count,Myeloid white cell count,Neutrophil count,-	UBXN4
ENSG00000270605	ENSG00000270605	-2.3731849071652	4.5675192670796e-4	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0002045	anti_sense	Q50	hsa-miR-19b-2-5p,hsa-miR-619-5p,hsa-miR-3620-5p,hsa-miR-4505,hsa-miR-4508,hsa-miR-1587,hsa-miR-5693,hsa-miR-5787,hsa-miR-6089	Aspartate aminotransferase measurement,-	DNAJC8
ENSG00000260135	MMP2-AS1	2.07589735613471	4.8376953625216e-4	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0111641	anti_sense	Q90		Abnormality of refraction,Age-related hearing impairment,-	CES1
ENSG00000273373	SLC16A4-AS1	-2.54021725483299	4.8656631664734e-4	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0005977	anti_sense	Q75		-	RBM15
ENSG00000225177	NHSL1-AS1	-1.84569406454347	4.8900233575645e-4	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0053831	anti_sense	Q75	hsa-miR-345-5p,hsa-miR-1228-5p,hsa-miR-4534,hsa-miR-6816-5p	-	CCDC28A
ENSG00000290873	LINC03009	2.22175122550092	5.2561671750042e-4	LPS_Whole_Cell_vs_Control_Whole_Cell	NA	NA	NA	NA	NA	UPK3B
ENSG00000255874	PRECSIT	2.70180152389075	5.6425571528699e-4	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0141617	integenic	Not conserved		Sitting height ratio	ANKRD10
ENSG00000285103	ENSG00000285103	1.31301687128487	5.7962320725189e-4	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0070557	anti_sense	Q75	hsa-miR-874-3p	Sporadic amyotrophic lateral sclerosis,Heart failure,-	IFNK
ENSG00000279833	ENSG00000279833	-4.65600107294165	5.9294547567597e-4	LPS_Whole_Cell_vs_Control_Whole_Cell	NA	NA	NA	NA	NA	APOBEC3H
ENSG00000239213	NCK1-DT	-1.79075933713427	5.9345341369746e-4	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0029189	anti_sense	Q90	hsa-miR-23a-5p,hsa-miR-135a-3p,hsa-miR-619-5p,hsa-miR-1268b,hsa-miR-4447,hsa-miR-3960,hsa-miR-6089	Lymphocyte count,Body mass index,-	STAG1
ENSG00000228022	HCG20	4.84813414538447	6.1612279146434e-4	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0049198	integenic	Not conserved			TUBB
ENSG00000242973	TDRD6-AS1	6.62040940383483	6.4438504352699e-4	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0050369	anti_sense	Q50	hsa-miR-567,hsa-miR-4447	Hashimoto's thyroiditis; Autoimmune thyroid disease; Graves disease,-	PLA2G7
ENSG00000227392	HPN-AS1	6.59656223384866	6.564729630579e-4	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0125567	anti_sense	Not conserved			LGI4
ENSG00000251364	SYT9-AS1	-1.9148599637622301	6.7283406263077e-4	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0082493	anti_sense	Q50	hsa-miR-6763-5p,hsa-miR-6895-5p	Serum igg glycosylation measurement,Stroke outcome severity measurement,-	CYB5R2
ENSG00000287255	ENSG00000287255	-2.30951698009894	7.0034725147284e-4	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0014389	anti_sense	Q50	hsa-miR-619-5p	Qt interval; Pr interval,Qt interval,Pr interval,Protein measurement,Qt interval; Tpe interval measurement,Electrocardiography,Bone fracture,Dna methylation,Heel bone mineral density,Forced expiratory volume; Response to bronchodilator,-	TMEM178A
ENSG00000289061	ENSG00000289061	3.42892333712989	7.066011766013e-4	LPS_Whole_Cell_vs_Control_Whole_Cell	NA	NA	NA	NA	NA	LPIN2
ENSG00000225963	ENSG00000225963	3.00114761410349	7.1007218983552e-4	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0022854	anti_sense	Q50	hsa-miR-6089,hsa-miR-6763-5p	Subcutaneous adipose tissue measurement,Metabolic rate measurement,Serum non-albumin protein measurement,Obsessive-compulsive disorder; Obsessive-compulsive symptom measurement,-	SP140
ENSG00000284693	LINC02606	-3.78035296101711	7.8688786190735e-4	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0000694	integenic	Q75	hsa-miR-1237-5p,hsa-miR-4281,hsa-miR-4722-3p,hsa-miR-6089	Body height,Fev/fec ratio,Phosphatidylcholine 34:3 measurement,-	CLSTN1
ENSG00000237753	SLC20A1-DT	-1.93239163723502	7.9312492478379e-4	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0017985	anti_sense	Q75	hsa-miR-619-5p,hsa-miR-3652,hsa-miR-4443,hsa-miR-4508,hsa-miR-378j	-	CKAP2L
ENSG00000253838	ENSG00000253838	6.43619989414399	7.9993482773609e-4	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0150187	sense	Q50		-	IDO1
ENSG00000237424	FOXD2-AS1	-2.95939671927594	8.24070792034e-4	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0003395	anti_sense	Q50	hsa-miR-505-5p,hsa-miR-619-5p,hsa-miR-665,hsa-miR-1207-5p,hsa-miR-4270,hsa-miR-4430,hsa-miR-4447,hsa-miR-4472,hsa-miR-3960,hsa-miR-5787,hsa-miR-6870-5p	Corneal topography,Brain volume measurement,Erythrocyte count,Balding measurement,Body height,Sleep duration; Low density lipoprotein cholesterol measurement,-	STIL
ENSG00000245293	CYP2U1-AS1	-6.74762021631031	8.7352934761401e-4	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0036264	anti_sense	Q50	hsa-miR-619-5p,hsa-miR-874-5p,hsa-miR-548l,hsa-miR-4328,hsa-miR-10392-3p	Monoclonal gammopathy,Protein measurement,Glycine measurement,-	LEF1
ENSG00000245552	LNCRNA-IUR	-4.34314402576024	9.1642358053254e-4	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0086562	anti_sense	Q90	hsa-miR-483-3p,hsa-miR-619-5p,hsa-miR-3960	Mean reticulocyte volume; Mean corpuscular hemoglobin concentration; Mean corpuscular hemoglobin; Mean corpuscular volume; Red blood cell density measurement; Erythrocyte count,Red blood cell distribution width,Eosinophil count,Common carotid intimal medial thickness,-	ENDOD1
ENSG00000230513	THAP7-AS1	-3.93665257207966	9.3882724724008e-4	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0134192	anti_sense,sense	Q50	hsa-miR-3652,hsa-miR-1268b	-	P2RX6
ENSG00000279277	ENSG00000279277	3.46375369221074	9.7731832423275e-4	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0027881	integenic	Q50	hsa-miR-5787	Bipolar disorder,-	CD47
ENSG00000276476	LINC00540	5.31324225524476	9.9773450432807e-4	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0143794	integenic	Q50			FGF9
ENSG00000258521	ENSG00000258521	2.19546327149298	0.00101320676953319	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0103731	anti_sense	Not conserved			SLC25A47
ENSG00000272720	ENSG00000272720	-6.89405992032316	0.00101715278073133	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0135382	anti_sense	Q75	hsa-miR-363-5p,hsa-miR-1238-5p,hsa-miR-3196,hsa-miR-3620-5p,hsa-miR-4446-3p,hsa-miR-4463,hsa-miR-4492,hsa-miR-4505,hsa-miR-1587,hsa-miR-3960,hsa-miR-4722-5p,hsa-miR-4758-5p	White matter microstructure measurement,Age-related hearing impairment,Tinnitus,Glioma; Central nervous system cancer; Glioblastoma multiforme,-	PICK1
ENSG00000290427	ENSG00000290427	-1.56930557328434	0.00107575066354302	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0123614	integenic	Not conserved		Susceptibility to chronic sinus infection measurement	MBD3L2B
ENSG00000253535	ADAM7-AS1	4.69268301843894	0.00116302782073287	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0064058	integenic	Not conserved			NEFL
ENSG00000282164	PEG13	-6.57022010444338	0.00119750917906539	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0150502	sense	Not conserved			TRAPPC9
ENSG00000231574	LINC02015	6.80159010245758	0.00121121209183295	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0030884	integenic	Q50	hsa-miR-619-5p,hsa-miR-4433a-3p,hsa-miR-4456,hsa-miR-4508,hsa-miR-6749-5p,hsa-miR-6807-3p,hsa-miR-7703,hsa-miR-4433b-3p,hsa-miR-8485	Systemic lupus erythematosus,Hba1c measurement; Hemoglobin a1 measurement,Hallux valgus,Anxiety disorder,Reaction time measurement,Visual perception measurement,Alcohol drinking,Unipolar depression,Brain volume measurement,Cortical surface area measurement,Chin morphology measurement,Corneal topography,Central corneal thickness,Cortical thickness,Heel bone mineral density,Cortical surface area measurement; Neuroimaging measurement,White matter microstructure measurement,Body height,Calcium measurement,Lobe attachment,Neuropsychological test,Venous thromboembolism,Pathological myopia,Gut microbiome measurement,Adolescent idiopathic scoliosis,Abnormality of the urinary system; Response to radiation,Neuroimaging measurement; Brain measurement,Cortical surface area measurement; Neuroimaging measurement; Brain measurement,Ovarian serous carcinoma; Ovarian carcinoma; Progression free survival,Response to cranial radiation therapy; Body mass index,-	KCNMB2
ENSG00000236591	UST-AS2	6.44516605354123	0.00129515684031728	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0054229	anti_sense	Not conserved	hsa-miR-4284,hsa-miR-4292,hsa-miR-8485		ZC3H12D
ENSG00000274508	ENSG00000274508	1.95789992390013	0.00131660904225803	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0111641	anti_sense	Q90		Abnormality of refraction,Age-related hearing impairment,-	CES1
ENSG00000244459	ENSG00000244459	-2.06684636775	0.00132579141980697	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0032293	integenic	Q90	hsa-miR-6836-3p	-	FAM53A
ENSG00000255284	GATD1-DT	-1.57604452801129	0.00132913004874103	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0082025	integenic	Q75	hsa-miR-4472		PANO1
ENSG00000258183	LINC02392	6.57138657327499	0.00138973456685573	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0092974	integenic	Not conserved	hsa-miR-6756-5p,hsa-miR-6803-5p	Interleukin 2 receptor antagonist measurement,Heel bone mineral density,Family history of lung cancer; Lung adenocarcinoma,-	TMTC3
ENSG00000286555	ENSG00000286555	1.29075536097092	0.0014192236329195701	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0085575	anti_sense	Q90	hsa-miR-6802-5p	Mean platelet volume,Rheumatoid arthritis,-	ATG16L2
ENSG00000290021	ENSG00000290021	1.52591514028394	0.00144463993505178	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0148005	anti_sense,sense	Q90	hsa-miR-4467	-	BCL6
ENSG00000290838	NCF1B	6.41865300918593	0.00147967791497897	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0058823	integenic	Not conserved	hsa-miR-619-5p		FKBP6
ENSG00000254554	ADM-DT	3.09843760395041	0.00162502095807222	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0082648	integenic	Q50	hsa-miR-6132	Waist-hip ratio; Bmi-adjusted waist-hip ratio,Appendicular lean mass,Total cholesterol measurement,Breast carcinoma,-	SBF2
ENSG00000198711	SSBP3-AS1	-4.29462007910492	0.00170046334757516	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0141766	anti_sense	Q50		-	MRPL37
ENSG00000223969	ENSG00000223969	1.79278108292026	0.00173375649596426	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0059467	anti_sense	Q75		-	FAM237B
ENSG00000286796	ENSG00000286796	-6.43161772669883	0.00183053601547836	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0014524	integenic	Q50	hsa-miR-4323,hsa-miR-4472,hsa-miR-6756-3p,hsa-miR-6783-3p,hsa-miR-6836-3p	Gastric carcinoma,Resistin measurement; Monocyte count,Monocyte count,Neutrophil percentage of leukocytes; Lymphocyte percentage of leukocytes,Neutrophil count	MTA3
ENSG00000288398	ENSG00000288398	-2.32337261474332	0.00184204547482459	LPS_Whole_Cell_vs_Control_Whole_Cell	NA	NA	NA	NA	NA	CPLANE2
ENSG00000289445	ENSG00000289445	4.72273089333933	0.00195783893383127	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0133098	integenic	Not conserved	hsa-miR-30b-3p,hsa-miR-6089	Heel bone mineral density,Body height,Bone fracture,Tpe interval measurement; Response to exercise,-	ETS2
ENSG00000289198	ENSG00000289198	6.45462549570457	0.00197549424636552	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0052920	integenic	Q90		-	MARCKS
ENSG00000235513	L3MBTL2-AS1	2.85244454685693	0.00200311473738524	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0135617	anti_sense	Q75	hsa-miR-6731-5p	Anorexia nervosa; Autism spectrum disorder; Depressive symptom measurement; Obsessive-compulsive disorder; Attention deficit hyperactivity disorder; Unipolar depression; Bipolar disorder; Tourette syndrome; Neuroticism measurement,Neuroticism measurement,Breast carcinoma,Red blood cell distribution width,Mood instability measurement,Anxiety measurement; Neuroticism measurement,Depressive symptom measurement; Unipolar depression; Wellbeing measurement; Bipolar disorder; Neuroticism measurement,-	CHADL
ENSG00000250519	ENSG00000250519	2.87113086653391	0.00208935491632948	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0086510	integenic	Q50		Serum alanine aminotransferase measurement,-	PANX1
ENSG00000287104	ENSG00000287104	-2.28300220063276	0.00215455489944127	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0032665	anti_sense	Not conserved			CCDC96
ENSG00000247572	CKMT2-AS1	-2.07260851477531	0.00223871861860824	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0043022	overlap_antisense,sense	Not conserved		Empathy measurement,-	ACOT12
ENSG00000272870	SAP30-DT	-2.82131108150953	0.00230671131653196	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0038589	anti_sense	Q75	hsa-miR-619-5p,hsa-miR-6791-3p	Eye colour measurement,-	SCRG1
ENSG00000188185	LINC00265	-1.63758168844784	0.00236865733280818	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0057380	sense	Not conserved	hsa-miR-3925-3p,hsa-miR-6089	-	RALA
ENSG00000285630	ENSG00000285630	6.40896872368887	0.00244557363659791	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0077044	integenic	Not conserved			MAP3K8
ENSG00000271216	LINC01050	1.36940032325993	0.00248032753612613	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0096679	anti_sense	Q75	hsa-miR-6735-3p	Cognitive decline measurement,-	EPSTI1
ENSG00000225434	LINC01504	-1.48089736736514	0.00259875469984166	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0071849	anti_sense	Q90	hsa-miR-619-5p,hsa-miR-4436a,hsa-miR-8485	Serum albumin measurement,Cognitive function measurement,-	GDA
ENSG00000224478	ENSG00000224478	3.71165807597174	0.00265857365798967	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0054727	integenic	Not conserved	hsa-miR-6089	Psoriasis vulgaris,Nicotine dependence symptom count; Depressive symptom measurement	FNDC1
ENSG00000234160	ENSG00000234160	-6.43095636124364	0.00266229364610723	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0071055	anti_sense,sense	Q90	hsa-miR-5196-5p,hsa-miR-1199-5p,hsa-miR-6089	Macrophage inflammatory protein 1b measurement,-	POLR1E
ENSG00000226791	LINC02611	-4.18173203807741	0.00270629157278904	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0017221	integenic	Q50	hsa-miR-6090,hsa-miR-7113-3p	Eosinophil count; Bipolar disorder,Bipolar disorder,Myositis,-	CRACDL
ENSG00000226822	LINC02785	-1.45787770368216	0.00273878690316131	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0005787	anti_sense	Q50	hsa-miR-1224-5p,hsa-miR-4508,hsa-miR-4638-3p,hsa-miR-6089	Bipolar disorder,Neutrophil count,Waist-hip ratio,Heel bone mineral density,Hba1c measurement,Hemoglobin a1 measurement,Mean corpuscular volume,Covid-19,Growth-regulated alpha protein measurement,Herpes zoster,Forced expiratory volume; Fev/fec ratio; Response to bronchodilator,Forced expiratory volume; Response to bronchodilator,-	NBPF6
ENSG00000228203	GRASLND	6.46434753527446	0.002740081969279	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0012734	anti_sense	Q50	hsa-miR-4710		CMPK2
ENSG00000247796	MOCS2-DT	-3.80310206206708	0.00277956023300385	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0041764	anti_sense	Q50	hsa-miR-6807-5p	Systemic juvenile idiopathic arthritis,Intelligence,Anorexia nervosa; Autism spectrum disorder; Obsessive-compulsive disorder; Attention deficit hyperactivity disorder; Unipolar depression; Bipolar disorder; Tourette syndrome,-	ITGA2
ENSG00000277007	ENSG00000277007	-6.49781541171976	0.00278716952593687	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0010635	sense	Q75		Bmi-adjusted hip circumference; Bmi-adjusted waist-hip ratio,Bmi-adjusted waist circumference; Bmi-adjusted waist-hip ratio,Bmi-adjusted hip circumference,Fev/fec ratio; Heel bone mineral density,Erythrocyte count,Chronic obstructive pulmonary disease,Fev/fec ratio,Gut microbiome measurement,Pulse pressure measurement,Bmi-adjusted waist circumference,Bmi-adjusted waist-hip ratio,Bmi-adjusted waist circumference; Bmi-adjusted hip circumference; Bmi-adjusted waist-hip ratio,Heel bone mineral density,Triglyceride measurement; Bmi-adjusted waist circumference,Protein measurement,Lean body mass,Hematocrit,-	LYPLAL1
ENSG00000235652	EPM2A-DT	-2.27995113944415	0.00280554429265354	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0054132	anti_sense	Not conserved	hsa-miR-6089	Heel bone mineral density	GRM1
ENSG00000203364	ENSG00000203364	6.33968279691072	0.00283361303630328	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0072823	anti_sense	Not conserved	hsa-miR-4488,hsa-miR-6089,hsa-miR-6763-5p	Serum alanine aminotransferase measurement; Aspartate aminotransferase measurement,Aspartate aminotransferase measurement,Dna methylation,Response to tenofovir	CARD19
ENSG00000288586	ENSG00000288586	-4.4811068834276	0.00284765849174228	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0070925	integenic	Q75	hsa-miR-4505	-	CD72
ENSG00000198468	FLVCR1-DT	-1.56759636814263	0.00288255107765886	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0010403	integenic	Q50	hsa-miR-6508-3p	-	SPATA45
ENSG00000228801	PCMTD1-DT	-1.39573269286878	0.0029879096643322	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0065245	integenic	Not conserved	hsa-miR-619-5p,hsa-miR-4525,hsa-miR-6726-5p	Glaucoma; Primary angle closure glaucoma,Sleep duration,-	NPBWR1
ENSG00000226312	CFLAR-AS1	3.36719091717756	0.00303482672712478	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0021529	anti_sense	Q50	hsa-miR-30b-3p	Total blood protein measurement,-	HYCC2
ENSG00000231830	ENSG00000231830	6.33968222872077	0.00322292458691591	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0140835	integenic	Not conserved			FLNA
ENSG00000262050	ENSG00000262050	-6.3808731444699	0.00325358106218619	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0113932	anti_sense	Q50	hsa-miR-619-5p	-	PAFAH1B1
ENSG00000234199	LINC01191	3.00425784602455	0.00328237702374185	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0018115	integenic	Not conserved			ACTR3
ENSG00000265907	ENSG00000265907	3.52933044564357	0.00346300215388537	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0119666	anti_sense	Q50		-	EMILIN2
ENSG00000228427	ENSG00000228427	-2.09030296490623	0.0034798257650553	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0138463	integenic	Q75	hsa-miR-30b-3p,hsa-miR-6089	Prostate carcinoma	ZMYM3
ENSG00000235954	TTC28-AS1	-1.44716611315284	0.00357846882661815	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0134754	anti_sense	Q75	hsa-miR-2467-3p,hsa-miR-5787	Hemoglobin measurement,Bmi-adjusted waist-hip ratio,Body height; Bmi-adjusted waist-hip ratio,Heel bone mineral density,Prostate carcinoma,Body mass index,Obesity,-	HSCB
ENSG00000214353	VAC14-AS1	2.75114308561432	0.00374984532106079	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0112453	anti_sense	Not conserved	hsa-miR-4456,hsa-miR-6891-3p		IL34
ENSG00000272768	ENSG00000272768	2.29954910799363	0.00385717902861538	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0057688	anti_sense	Q50	hsa-miR-1301-3p,hsa-miR-1237-5p,hsa-miR-3960,hsa-miR-5691	Platelet count,Aging,Reaction time measurement,Reticulocyte count,-	PPIA
ENSG00000261218	ENSG00000261218	-6.35947886718175	0.00391281434048828	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0113011	sense	Not conserved	hsa-miR-619-5p,hsa-miR-637,hsa-miR-920,hsa-miR-4447,hsa-miR-4468,hsa-miR-6752-3p,hsa-miR-6808-5p,hsa-miR-6810-3p,hsa-miR-6813-5p	Gut microbiome measurement,Mean platelet volume,Response to antineoplastic agent; Response to carboplatin	PLCG2
ENSG00000237886	NALT1	-6.34933170893267	0.00404743671525739	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0075266	integenic	Q75	hsa-miR-3612,hsa-miR-4674,hsa-miR-5088-3p	Sucrose liking measurement,-	EGFL7
ENSG00000232504	ST3GAL5-AS1	3.68007584749649	0.00415361190322967	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0016544	anti_sense	Q50	hsa-miR-619-5p,hsa-miR-4298	Mean platelet volume,Erythrocyte count,Monocyte percentage of leukocytes,Testosterone measurement,-	ATOH8
ENSG00000229873	OGFR-AS1	2.04172534300971	0.0042155218281466	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0131564	anti_sense	Q90	hsa-miR-1271-5p,hsa-miR-6800-3p	-	TCFL5
ENSG00000225792	SNX10-AS1	1.49823221284429	0.00430460651658071	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0056814	anti_sense	Q90	hsa-miR-4505,hsa-miR-1587,hsa-miR-3960	Bmi-adjusted waist-hip ratio,Blood urea nitrogen measurement; Bmi-adjusted waist circumference,Body weight; Body mass index,Bmi-adjusted waist circumference; Bmi-adjusted waist-hip ratio,Vaginal microbiome measurement,-	HNRNPA2B1
ENSG00000230641	USP12-DT	4.46537598274074	0.00442133024235707	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0095918	integenic	Not conserved		Creatinine measurement; Serum gamma-glutamyl transferase measurement; Glomerular filtration rate	RPL21
ENSG00000262223	LINC03048	6.26682018547991	0.00455059914351149	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0119251	integenic	Q50	hsa-miR-132-5p,hsa-miR-619-5p,hsa-miR-3620-5p,hsa-miR-4492,hsa-miR-4505,hsa-miR-1587,hsa-miR-6769b-5p,hsa-miR-4433b-3p	Dental caries; Bmi-adjusted hip circumference; Dentures,Self reported educational attainment,Body height,Systolic blood pressure,Beta blocking agent use measurement,-	SLC38A10
ENSG00000205057	CLLU1-AS1	4.47350194252246	0.004578725315336	LPS_Whole_Cell_vs_Control_Whole_Cell	NA	NA	NA	NA	NA	BTG1
ENSG00000257964	ENSG00000257964	4.52162178909839	0.00512691104959406	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0090959	anti_sense	Q50			FAM186B
ENSG00000270164	LINC01480	-2.01968751469172	0.00543999899294758	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0126205	sense	Not conserved	hsa-miR-619-5p,hsa-miR-6803-5p		CEACAM21
ENSG00000179406	LINC00174	-1.8075998765956	0.00562143731313904	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0058597	integenic	Not conserved			GUSB
ENSG00000290735	ENSG00000290735	-6.40204793865088	0.00563785728911744	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0006949	integenic	Not conserved			H3-7
ENSG00000250378	ENSG00000250378	2.58058283077586	0.00570703337829845	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0045056	sense	Not conserved			SLC25A48
ENSG00000257194	ENSG00000257194	3.91032495681773	0.00587315205468172	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0092957	anti_sense	Q90	hsa-miR-619-5p,hsa-miR-4787-5p,hsa-miR-6749-3p,hsa-miR-6797-5p,hsa-miR-8485	Diastolic blood pressure,Risk-taking behaviour,Pulse pressure measurement; Mean arterial pressure; Alcohol drinking; Systolic blood pressure; Agents acting on the renin-angiotensin system use measurement,Hair colour measurement,Prostate carcinoma,Calcium measurement,Heel bone mineral density,Age at onset,Body mass index,Body height; Body mass index,Coronary artery disease,Body height,Chronotype measurement,Mean corpuscular volume,Magnesium measurement,Spine bone mineral density,Febrile seizure (within the age range of 3 months to 6 years); Mmr-related febrile seizures,Volumetric bone mineral density,Bone density,Heart rate,Biological sex,Systolic blood pressure,Creatinine measurement,C-reactive protein measurement,Pulse pressure measurement; Systolic blood pressure,Optic disc size measurement,Chronotype measurement; Heel bone mineral density,Diffusing capacity of the lung for carbon monoxide,Osteoarthritis, hip, osteoarthritis, knee,Diastolic blood pressure; Alcohol consumption measurement,Response to citalopram; Response to escitalopram; Triglyceride measurement,Ischemic stroke; Coronary artery disease,Diastolic blood pressure; Smoking status measurement; Systolic blood pressure,Body fat percentage,-	TMTC3
ENSG00000286872	ENSG00000286872	-2.485746536173	0.0058846408988592	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0107736	integenic	Not conserved	hsa-miR-4447,hsa-miR-4505		HDGFL3
ENSG00000236901	MIR600HG	-2.01240661263198	0.00603561756467889	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0074272	sense	Not conserved		-	STRBP
ENSG00000267751	BSG-AS1	-2.66738274201376	0.00615706677591757	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0122891	integenic	Not conserved			POLRMT
ENSG00000272941	ENSG00000272941	1.19123811748384	0.00654435837810265	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0061535	anti_sense	Q50		-	TMEM140
ENSG00000125462	MIR9-1HG	4.04179227645683	0.00668915348839588	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0007588	sense	Not conserved			MEF2D
ENSG00000280832	GSEC	2.53557078324493	0.00670857616225737	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0088026	anti_sense	Q50		Neutrophil count,Low density lipoprotein cholesterol measurement,-	KIRREL3
ENSG00000262877	ENSG00000262877	-3.40236739279082	0.00689524515726712	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0119254	integenic	Q75	hsa-miR-762,hsa-miR-6803-5p,hsa-miR-6813-5p		SLC38A10
ENSG00000204960	BLACE	6.13523095891245	0.00706958992694386	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0062567	anti_sense	Not conserved		Angina pectoris; Coronary artery disease,Neuroticism measurement,Hair colour measurement,Age at onset,Thyroid peroxidase antibody measurement; Anti-thyroglobulin antibody measurement,Visual perception measurement,Coronary artery calcification,Stem cell growth factor beta measurement,Response to carboplatin; Ovarian carcinoma; Response to paclitaxel; Progression free survival,-	CNPY1
ENSG00000250802	ZBED3-AS1	-1.34932811328547	0.0071718762036779	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0042820	anti_sense,sense	Q50	hsa-miR-619-5p,hsa-miR-877-3p,hsa-miR-4505,hsa-miR-4722-5p,hsa-miR-6803-5p,hsa-miR-6892-3p	Self-injurious behavior,Fasting blood glucose measurement,Autism,Glucose measurement; Fasting blood glucose measurement,Hemoglobin a1 measurement; Bmi-adjusted waist-hip ratio,Body mass index,Glucose measurement,Waist-hip ratio; Bmi-adjusted waist-hip ratio,Hba1c measurement,Glucose measurement; Hba1c measurement,Hba1c measurement; Bmi-adjusted waist-hip ratio,Dental caries,Testosterone measurement,Hematocrit; Hemoglobin measurement,Hematocrit; Hemoglobin measurement; Red blood cell density measurement; Erythrocyte count,Thyroid stimulating hormone measurement; Erythrocyte count,Hematocrit; Hemoglobin measurement; Red blood cell density measurement,Hemoglobin measurement,Bmi-adjusted waist-hip ratio,-	NA
ENSG00000228315	GUSBP11	-1.28483080509369	0.00725259277405707	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0134423	integenic	Not conserved		Adolescent idiopathic scoliosis	DRICH1
ENSG00000176593	ENSG00000176593	-1.46828401326716	0.0073352711672447	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0127911	anti_sense	Not conserved	hsa-miR-619-5p,hsa-miR-762,hsa-miR-1203,hsa-miR-4433a-3p,hsa-miR-6086		ZSCAN1
ENSG00000232442	MHENCR	-1.08351386523208	0.00738368726299739	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0131657	anti_sense	Q90	hsa-miR-3620-5p,hsa-miR-4505,hsa-miR-1587,hsa-miR-6786-5p	-	RTEL1
ENSG00000228393	LINC01004	1.28202317361327	0.00750145507445213	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0060291	anti_sense	Q90	hsa-miR-483-3p,hsa-miR-3620-5p,hsa-miR-1268b,hsa-miR-4505,hsa-miR-1587,hsa-miR-6779-3p,hsa-miR-6887-3p	Intelligence; Mathematical ability,Vital capacity,Intelligence,Risk-taking behaviour,Vitamin d measurement,Interleukin-6 measurement,Self reported educational attainment; Intelligence,-	SRPK2
ENSG00000267365	KCNJ2-AS1	2.929525639787	0.0075610276637184	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0118455	anti_sense	Q50		Body weight,-	ABCA5
ENSG00000279762	ENSG00000279762	6.12407541525804	0.00756272014831529	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0115783	anti_sense	Q90	hsa-miR-30b-3p,hsa-miR-6089	Systolic blood pressure,-	MYO1D
ENSG00000228140	EFHD2-AS1	6.157515603264	0.00760456140486787	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0001073	anti_sense	Q50	hsa-miR-8085	Alcoholic pancreatitis,-	CASP9
ENSG00000232759	STEAP1B-AS1	6.12401913934717	0.00800297578803185	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0056606	anti_sense	Q50	hsa-miR-892b,hsa-miR-4472,hsa-miR-4534	Atopic asthma,C-reactive protein measurement,Unipolar depression,-	IL6
ENSG00000254531	FLJ20021	-1.48433040028987	0.00811944224326079	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0148159	anti_sense	Not conserved	hsa-miR-6780a-3p	-	BANK1
ENSG00000231290	APCDD1L-DT	6.12399570952688	0.00819290650926686	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0131258	integenic	Not conserved	hsa-miR-6779-5p	Wellbeing measurement	STX16
ENSG00000226004	LINC02528	2.93453911031365	0.00825018358966814	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0053802	integenic	Q50		Eosinophil count; Ejection fraction measurement; Eosinophil percentage of leukocytes,Cardiac troponin t measurement,Rheumatoid arthritis,-	PERP
ENSG00000288999	ENSG00000288999	2.03094644165901	0.00825760712155102	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0010910	integenic	Not conserved	hsa-miR-4467		CAPN2
ENSG00000251393	ENSG00000251393	2.76833686966952	0.00884038675627267	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0102349	anti_sense	Q75	hsa-miR-619-5p	Self reported educational attainment,Platelet component distribution width,Platelet crit,-	RIOX1
ENSG00000227540	DNAJC9-AS1	-6.18489662382702	0.00887588029408088	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0078831	anti_sense	Q90	hsa-miR-4463,hsa-miR-6089	-,Glomerular filtration rate	FAM149B1
ENSG00000256746	MADD-AS1	2.31805284681238	0.00887588029408088	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0084043	intronic_antisense	Q75	hsa-miR-6747-3p		ACP2
ENSG00000289353	ENSG00000289353	-1.64802227456992	0.00901080561388262	LPS_Whole_Cell_vs_Control_Whole_Cell	NA	NA	NA	NA	NA	CMTM1
ENSG00000251022	THAP9-AS1	-1.02692645686819	0.00927168384341575	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0035549	anti_sense,sense	Not conserved		Neutrophil percentage of leukocytes,Eosinophil count,-	SEC31A
ENSG00000254966	IGSF22-AS1	-3.69413660102771	0.00928432402344477	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0083030	anti_sense	Q75	hsa-miR-6086	-	TMEM86A
ENSG00000264772	ENSG00000264772	3.15654438330551	0.00929170553396709	LPS_Whole_Cell_vs_Control_Whole_Cell	NA	NA	NA	NA	NA	EIF4A1
ENSG00000254054	ENSG00000254054	-2.30642753065851	0.0100587493621136	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0063689	anti_sense	Q50	hsa-miR-331-3p,hsa-miR-3194-3p,hsa-miR-4257,hsa-miR-2467-3p		PCM1
ENSG00000289293	ENSG00000289293	1.37083273655564	0.0101217895610015	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0117931	integenic	Q90	hsa-miR-4296,hsa-miR-4322,hsa-miR-4265,hsa-miR-3960		MED13
ENSG00000263327	TAPT1-AS1	-1.99937851116184	0.0102461965538271	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0033093	anti_sense	Q75	hsa-miR-4310,hsa-miR-6882-5p	Self reported educational attainment,Intelligence,Intelligence; Mathematical ability,Verbal-numerical reasoning measurement,Cognitive function measurement,Systemic juvenile idiopathic arthritis,Temporal horn of lateral ventricle volume measurement,Duchenne muscular dystrophy; Disease progression measurement,-	CD38
ENSG00000234076	TPRG1-AS1	1.88317829503487	0.0102986385750765	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0031482	anti_sense	Q50	hsa-miR-619-5p	-	P3H2
ENSG00000235151	ENSG00000235151	6.03888133818216	0.0103568612457775	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0023730	integenic	Not conserved	hsa-miR-6089	Eosinophil count; Eosinophil percentage of leukocytes,-	RTP5
ENSG00000236849	LINC01474	-2.82920925292423	0.0105028412217691	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0071876	integenic	Q50		-	ALDH1A1
ENSG00000253557	ENSG00000253557	6.02698877344556	0.0108744180646599	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0063737	integenic	Q50	hsa-miR-7155-5p	Bone quantitative ultrasound measurement,Platelet count,Mean platelet volume,Gout,Smooth surface dental caries,Urate measurement,Intelligence,Insulin measurement,Telomere length,-	PSD3
ENSG00000289970	ENSG00000289970	4.29721476183023	0.0110591872530394	LPS_Whole_Cell_vs_Control_Whole_Cell	NA	NA	NA	NA	NA	GPX3
ENSG00000288046	ENSG00000288046	-6.12442307775516	0.0111508304391278	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0047831	integenic	Q75	hsa-miR-151a-5p,hsa-miR-151b,hsa-miR-4710	Serum alanine aminotransferase measurement,Reticulocyte count; Reticulocyte measurement,Bmi-adjusted hip circumference,Mean reticulocyte volume; Mean corpuscular volume; Erythrocyte count,Mean corpuscular volume,Monocyte count,Pelvic organ prolapse,Bmi-adjusted waist-hip ratio; Bmi-adjusted hip circumference; Urate measurement,-	LY86
ENSG00000232803	SLCO4A1-AS1	6.10058259512855	0.0113361586684331	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0146997	anti_sense	Q75	hsa-miR-5196-5p	Human papilloma virus infection; Oral cavity cancer,-	TCFL5
ENSG00000291263	SMG1P7	-2.36942843270283	0.0113370699539988	LPS_Whole_Cell_vs_Control_Whole_Cell	NA	NA	NA	NA	NA	EXOSC6
ENSG00000273002	ARHGEF2-AS2	1.49677603504156	0.0114250824442111	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0007540	anti_sense	Q75		Comparative body size at age 10, self-reported,-	RXFP4
ENSG00000271270	TMCC1-DT	-1.55239341959698	0.0117976692224185	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0028917	integenic	Q75	hsa-miR-486-3p,hsa-miR-3162-5p	Bmi-adjusted waist circumference; Bmi-adjusted hip circumference	TRH
ENSG00000271122	HERPUD2-AS1	-1.19310617044824	0.0123196713153979	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0057228	anti_sense	Q50		-	SEPTIN7
ENSG00000270049	ATP6V0D1-DT	-2.04917536080815	0.0123218559462967	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0112213	anti_sense	Q75	hsa-miR-619-5p,hsa-miR-4433a-3p,hsa-miR-4740-3p	Agouti-related protein measurement,Mean corpuscular hemoglobin concentration,Mean reticulocyte volume; Mean corpuscular volume; Mean corpuscular hemoglobin,-	RIPOR1
ENSG00000287037	ENSG00000287037	4.3072510676625	0.01256598086187	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0035183	overlap_antisense	Not conserved		Serum metabolite measurement,Ulcerative colitis,C-x-c motif chemokine 5 measurement; Inflammatory bowel disease,Cxcl5 measurement; C-x-c motif chemokine 5 measurement; Blood protein measurement,Blood protein measurement,Growth-regulated alpha protein measurement,Coronary artery calcification,Protein measurement; Blood metabolite measurement; Amino acid measurement,Body mass index; Urate measurement,-	MTHFD2L
ENSG00000277511	ENSG00000277511	2.92453329320938	0.0127234411174964	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0115754	integenic	Not conserved	hsa-miR-6089,hsa-miR-7847-3p	-	RHOT1
ENSG00000261971	MMP25-AS1	-2.18488315340455	0.0129345533691484	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0109107	anti_sense	Q75	hsa-miR-455-3p,hsa-miR-619-5p,hsa-miR-3178,hsa-miR-4286,hsa-miR-4472,hsa-miR-4498,hsa-miR-3960,hsa-miR-4787-5p,hsa-miR-6132,hsa-miR-6767-5p,hsa-miR-6779-5p,hsa-miR-6803-5p,hsa-miR-6836-5p,hsa-miR-6860,hsa-miR-8072	-	BICDL2
ENSG00000286207	ENSG00000286207	1.3938442990291	0.0129940022859179	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0146630	anti_sense	Q50			PRPF40A
ENSG00000227354	RBM26-AS1	-1.76854851645531	0.0133821057340656	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0098147	anti_sense	Q50	hsa-miR-619-5p,hsa-miR-4463	-	NDFIP2
ENSG00000289515	ENSG00000289515	2.73652541317592	0.0134087027711394	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0035305	anti_sense	Q90			CCDC158
ENSG00000228878	SEPTIN7-DT	-1.76871626043644	0.0134379904800681	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0057234	integenic	Not conserved	hsa-miR-8485		HERPUD2
ENSG00000255443	CD44-AS1	2.43023837448727	0.0137665939719844	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0083610	anti_sense	Q50		-	SLC1A2
ENSG00000261423	TMEM202-AS1	2.35432246908505	0.0143553952184529	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0107060	integenic	Not conserved	hsa-miR-4675		HEXA
ENSG00000286972	ENSG00000286972	-2.85117474804282	0.0146622735075323	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0146843	integenic	Q90		Abnormal paneth cell measurement,-	TOP1
ENSG00000236756	DNAJC9-AS1	-3.81739815485493	0.0147806039571111	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0078831	anti_sense	Q90	hsa-miR-4463,hsa-miR-6089	-,Glomerular filtration rate	FAM149B1
ENSG00000281162	LINC01127	-1.57809492466938	0.014879835841334	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0017393	integenic	Q50	hsa-miR-939-3p,hsa-miR-6728-3p,hsa-miR-6737-3p	Eosinophil count,Protein measurement,St2 protein measurement,Neutrophil count,-	IL1R2
ENSG00000268204	ENSG00000268204	-3.19379621159332	0.0153750819749278	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0123659	anti_sense,sense	Q50	hsa-miR-4726-3p,hsa-miR-6514-3p,hsa-miR-6803-5p	Neuropathic pain,-	PCP2
ENSG00000236682	MAP3K2-DT	-1.14950551660693	0.0154046417819734	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0018617	anti_sense	Q50	hsa-miR-619-5p,hsa-miR-1237-5p,hsa-miR-4292,hsa-miR-3180,hsa-miR-4488,hsa-miR-3960	Protein c measurement,Self reported educational attainment,-	PROC
ENSG00000288771	ENSG00000288771	-1.10098563515157	0.0155880276271278	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0071712	anti_sense	Q50		Fasting blood glucose measurement	PRKACG
ENSG00000233203	DHCR24-DT	-6.06284115931931	0.0161095974388816	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0003806	anti_sense	Q75	hsa-miR-141-3p,hsa-miR-200a-3p,hsa-miR-4279,hsa-miR-6085,hsa-miR-6749-5p,hsa-miR-7155-5p	Total cholesterol measurement; Apolipoprotein b measurement; Low density lipoprotein cholesterol measurement,-	LEXM
ENSG00000290418	TPTEP1	-1.06239615608608	0.0161876124585267	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0133819	integenic	Not conserved		-	IL17RA
ENSG00000289365	ENSG00000289365	2.21179009688613	0.0164893478751733	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0139497	integenic	Q50			NXT2
ENSG00000273855	ENSG00000273855	-2.65813417776716	0.0165331211832937	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0105214	sense	Q75	hsa-miR-4293,hsa-miR-5088-3p		PLCB2
ENSG00000289100	ENSG00000289100	2.67675866407495	0.0170245782075458	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0049520	anti_sense	Q50	hsa-miR-619-5p,hsa-miR-7846-3p		PFDN6
ENSG00000257127	CLLU1	5.97721626592292	0.017075613537228	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0093062	anti_sense	Q50		Methionine measurement,Sudden cardiac arrest,-	PLEKHG7
ENSG00000272078	ENSG00000272078	2.35473041018595	0.0171022544425876	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0000789	anti_sense	Q50	hsa-miR-505-3p		PEX14
ENSG00000260231	KDM7A-DT	1.36092427087674	0.0171745872977106	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0061777	anti_sense	Q90			TBXAS1
ENSG00000265778	ZNF516-AS1	-3.27268922209191	0.0173064785874052	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0122568	anti_sense	Q90	hsa-miR-4667-3p,hsa-miR-4675		ZNF236
ENSG00000291145	PPP5D1P	-1.75941322928761	0.0173907368654984	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0145952	sense	Not conserved		Vital capacity,Reticulocyte count; P wave terminal force measurement,Late-onset alzheimers disease,Eosinophil count,-	PNMA8B
ENSG00000271643	PDCD6IP-DT	1.06164495235861	0.0174243496158677	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0025078	anti_sense	Not conserved		-	CLASP2
ENSG00000238113	LINC01410	-1.60247243267451	0.0174508159944369	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0071451	integenic	Not conserved	hsa-miR-3620-5p,hsa-miR-3925-3p,hsa-miR-4639-3p,hsa-miR-6784-5p	-	CNTNAP3C
ENSG00000214870	LINC02981	-1.37754227038924	0.0177469462424192	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0056819	integenic	Not conserved			SNX10
ENSG00000259307	PLCB2-AS1	-6.0893280097081	0.0180357432194182	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0105216	anti_sense	Q50	hsa-miR-4447		INAFM2
ENSG00000290720	ZNF542P	-1.07968822700645	0.0183465146120992	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0127752	anti_sense	Not conserved	hsa-miR-939-3p		ZNF583
ENSG00000291135	FCGR1BP	-1.63375002904724	0.018463918537941	LPS_Whole_Cell_vs_Control_Whole_Cell	NA	NA	NA	NA	NA	SRGAP2C
ENSG00000287494	ENSG00000287494	2.59465613859464	0.0190160917287949	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0144545	anti_sense	Q50	hsa-miR-5787	Fev/fec ratio,Platelet component distribution width	PIF1
ENSG00000290554	ADCY10P1	-1.9823190208969	0.0191778314750694	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0049993	integenic	Q50		-	NFYA
ENSG00000268027	ENSG00000268027	-3.16068826660632	0.0192132154468581	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0126205	sense	Not conserved	hsa-miR-619-5p,hsa-miR-6803-5p		CEACAM21
ENSG00000213888	LINC01521	-3.74543746670546	0.0197366340084123	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0147275	integenic	Q50	hsa-miR-619-5p	Bmi-adjusted waist circumference; Bmi-adjusted waist-hip ratio,-	DRG1
ENSG00000228554	ENSG00000228554	5.88365290027895	0.0199644969945797	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0149918	anti_sense	Q50		-	MPLKIP
ENSG00000231530	ENSG00000231530	5.88364491928901	0.0200648162681786	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0096651	anti_sense	Q75	hsa-miR-4430,hsa-miR-6878-3p	-	VWA8
ENSG00000288056	ENSG00000288056	5.92344044706952	0.0202641270025883	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0149542	integenic	Not conserved			FBXO30
ENSG00000260552	COSMOC	-5.914855159099	0.0208958966547892	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0120942	anti_sense	Q50	hsa-miR-604	Tnf-related apoptosis-inducing ligand measurement	SLC39A6
ENSG00000247982	LINC00926	1.33551278148939	0.021462154492998	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0106171	sense	Q50	hsa-miR-4492,hsa-miR-4508,hsa-miR-6803-5p	-	TCF12
ENSG00000285693	ENSG00000285693	-1.38414876596916	0.0216030431298999	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0085586	sense	Q50	hsa-miR-4279,hsa-miR-4492,hsa-miR-5589-5p	Protein measurement,Platelet count,Aspartate aminotransferase measurement,Serum alanine aminotransferase measurement	STARD10
ENSG00000287382	ENSG00000287382	2.97351654932121	0.0216590102283583	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0034557	anti_sense	Q50	hsa-miR-6829-3p	-	NMU
ENSG00000251365	LINC02236	-6.025584373267	0.0217480711262956	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0039931	integenic	Not conserved	hsa-miR-4749-3p		TENT4A
ENSG00000228649	SNHG26	1.67228151281562	0.022164334617035	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0056623	integenic	Q75	hsa-miR-483-3p,hsa-miR-4320	Alkaline phosphatase measurement,-	IL6
ENSG00000245694	CRNDE	-1.80380508994505	0.0222160642136287	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0111608	integenic	Q50	hsa-miR-619-5p,hsa-miR-4266,hsa-miR-6746-5p,hsa-miR-6754-5p,hsa-miR-10392-3p	Adolescent idiopathic scoliosis,Diet measurement; Body mass index,-	IRX3
ENSG00000290525	GBP1P1	5.95034567261827	0.0224860467810418	LPS_Whole_Cell_vs_Control_Whole_Cell	NA	NA	NA	NA	NA	GBP6
ENSG00000215022	ENSG00000215022	1.6835908136851	0.0231378975587309	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0048149	anti_sense,sense	Q90		-	TBC1D7
ENSG00000230149	ENSG00000230149	2.78006168380683	0.023293099366134	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0135439	anti_sense,sense	Q90	hsa-miR-1227-5p,hsa-miR-500b-3p	White matter microstructure measurement,-	GTPBP1
ENSG00000258982	ENSG00000258982	5.86994277703664	0.023294221971071	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0103712	anti_sense	Q90	hsa-miR-939-5p,hsa-miR-3196,hsa-miR-3197,hsa-miR-3918,hsa-miR-4430,hsa-miR-4505,hsa-miR-3960,hsa-miR-4674,hsa-miR-5787,hsa-miR-6089,hsa-miR-6850-3p,hsa-miR-6852-5p,hsa-miR-7108-3p,hsa-miR-10392-3p	Frontal theta oscillation measurement,Erythrocyte count,Metastasis measurement; Disease progression measurement,-	DEGS2
ENSG00000287896	ENSG00000287896	5.74007986335448	0.0233597039002505	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0145772	anti_sense	Q50		-	DHX34
ENSG00000180066	LINC02870	-6.11737234713319	0.0234450394232692	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0081790	integenic	Q50	hsa-miR-1227-5p,hsa-miR-4485-5p,hsa-miR-4514,hsa-miR-4763-3p,hsa-miR-5001-3p,hsa-miR-6813-5p	-	PWWP2B
ENSG00000233175	FMNL1-AS1	2.82897918353116	0.0244317060203819	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0116843	anti_sense	Q90	hsa-miR-4286	-	SPATA32
ENSG00000275665	ENSG00000275665	5.93731124463762	0.0244818255163825	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0116183	anti_sense	Q90	hsa-miR-892b,hsa-miR-4492,hsa-miR-4632-3p,hsa-miR-6795-3p,hsa-miR-6886-3p		PCGF2
ENSG00000285632	ENSG00000285632	-3.91986186509046	0.0244818255163825	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0064623	anti_sense	Not conserved	hsa-miR-619-5p	-	PLPP5
ENSG00000245105	A2M-AS1	-3.12266386468439	0.0246631346120307	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0089113	anti_sense	Not conserved	hsa-miR-1228-5p,hsa-miR-4307,hsa-miR-3620-5p,hsa-miR-4505,hsa-miR-6090	-	KLRG1
ENSG00000289381	ENSG00000289381	-3.68455474022864	0.0247582965207684	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0096195	anti_sense	Not conserved		Testosterone measurement	ZAR1L
ENSG00000186235	LINC02610	-2.77681375353794	0.0248572282898588	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0023418	integenic	Not conserved	hsa-miR-3620-5p,hsa-miR-4492,hsa-miR-4505,hsa-miR-1587,hsa-miR-4685-3p,hsa-miR-6753-5p,hsa-miR-6784-5p,hsa-miR-1273h-5p,hsa-miR-7846-3p,hsa-miR-8072	Chronotype measurement	HES6
ENSG00000237499	WAKMAR2	2.40728593013957	0.025183305986455	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0053791	anti_sense	Q50	hsa-miR-619-5p,hsa-miR-4472,hsa-miR-4492,hsa-miR-6728-3p,hsa-miR-6803-5p,hsa-miR-6842-3p	Systemic lupus erythematosus,Total blood protein measurement,Eosinophil count,Eczema; Allergic rhinitis,Rheumatoid arthritis; Systemic lupus erythematosus,C-reactive protein measurement,-	PERP
ENSG00000258018	LINC02457	2.61670147275635	0.025196734162194	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0094325	integenic	Not conserved			MAP1LC3B2
ENSG00000244041	LINC01011	-1.29529177610589	0.0254462052166227	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0047546	sense	Not conserved		Urinary metabolite measurement,Protein measurement,-	NQO2
ENSG00000238198	LRIG2-DT	-6.02682426737263	0.0256720785056182	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0006161	integenic	Not conserved			SLC16A1
ENSG00000255050	ENSG00000255050	-5.81322090277687	0.0257640745864375	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0069297	anti_sense	Q50	hsa-miR-4505,hsa-miR-6744-3p	Interleukin 18 measurement	GSDMD
ENSG00000231856	ENSG00000231856	1.73349737342109	0.0261654311984422	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0097204	anti_sense	Not conserved	hsa-miR-4530,hsa-miR-5089-5p	-	WDFY2
ENSG00000288928	ENSG00000288928	2.88589318330759	0.0263118359597214	LPS_Whole_Cell_vs_Control_Whole_Cell	NA	NA	NA	NA	NA	HIF1A
ENSG00000232628	ENSG00000232628	-3.71415454930879	0.026496091837377	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0010945	integenic	Not conserved		Ceramide measurement	NVL
ENSG00000280434	ENSG00000280434	2.43763365403768	0.0268010615708545	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0147307	sense	Not conserved		-	PARVB
ENSG00000249069	LINC01033	5.75402620894381	0.0270807130206931	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0041819	sense	Q50	hsa-miR-204-3p,hsa-miR-619-5p,hsa-miR-6875-3p,hsa-miR-8485	Red blood cell distribution width,Reticulocyte count; Reticulocyte measurement; Red blood cell distribution width,Reticulocyte count; Reticulocyte measurement,Reticulocyte count,Cognitive decline measurement,Guanosine diphosphate measurement,Dna methylation,Protein measurement,-	HSPB3
ENSG00000224424	PRKAR2A-AS1	-2.33734381082958	0.0273687988404033	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0025884	anti_sense	Q75	hsa-miR-3960	-	ARIH2
ENSG00000261924	ENSG00000261924	-6.02734761807393	0.0276263446873655	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0145391	anti_sense	Not conserved		Self reported educational attainment	AATK
ENSG00000235366	LINC01055	5.85567214243783	0.0280203539419829	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0096844	integenic	Not conserved		-	ERICH6B
ENSG00000263718	SEPTIN9-DT	1.12229262216425	0.02825671393184	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0118918	anti_sense	Q50	hsa-miR-1227-5p,hsa-miR-8485	Virologic response measurement; Response to abacavir,-	SRSF2
ENSG00000225756	DBH-AS1	-1.28650776465626	0.0287297690494327	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0141604	anti_sense	Not conserved		Diastolic blood pressure; Cardiovascular disease; Mean arterial pressure; Systolic blood pressure; Calcium channel blocker use measurement,-	SARDH
ENSG00000291137	GBAP1	-2.59970150661779	0.0288336837189169	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0007483	integenic	Not conserved			THBS3
ENSG00000272463	ENSG00000272463	4.09713257783938	0.028996957861047	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0047304	integenic	Q50		-	EXOC2
ENSG00000291106	LINC00888	-1.0101362690252	0.0291289433358648	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0031153	integenic	Q75		-	B3GNT5
ENSG00000261136	ENSG00000261136	-2.27270322526527	0.0291728563992294	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0105179	anti_sense	Not conserved			EIF2AK4
ENSG00000266378	ENSG00000266378	5.61150751001132	0.029661132781978	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0114722	intronic_sense	Q50			HS3ST3B1
ENSG00000266978	ENSG00000266978	5.75390122988333	0.0304040125984842	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0123918	integenic	Not conserved		-	ZGLP1
ENSG00000260360	ENSG00000260360	2.01384883821081	0.0304274428187491	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0008786	anti_sense	Q75	hsa-miR-619-5p,hsa-miR-10392-3p	Prostate carcinoma,-	TOR1AIP2
ENSG00000248019	FAM13A-AS1	-1.32369543383005	0.0307415816054992	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0035768	anti_sense	Q75		Fev/fec ratio,-	HERC3
ENSG00000260588	ENSG00000260588	-2.36001802887267	0.0309171371192946	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0064845	sense	Not conserved	hsa-miR-1268b	Mean reticulocyte volume	ANK1
ENSG00000246334	PRR7-AS1	-2.2372936223909	0.0309521313146178	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0046927	anti_sense	Q75	hsa-miR-4763-3p,hsa-miR-6089,hsa-miR-7160-5p	Chronotype measurement,-	DBN1
ENSG00000246430	LINC00968	-3.31038001430297	0.0310606785125776	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0065481	integenic	Q75	hsa-miR-6791-5p		PENK
ENSG00000225331	LINC01678	1.88647476500166	0.0313999341427784	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0133495	anti_sense	Not conserved			ICOSLG
ENSG00000291155	CT75	3.03507789935177	0.0323255444187562	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0022522	integenic	Q50	hsa-miR-4308,hsa-miR-4467,hsa-miR-3960	Susceptibility to scarlet fever measurement,-	SGPP2
ENSG00000276809	ENSG00000276809	4.0370328941616	0.032731035358234	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0098739	sense	Not conserved			DNAJC3
ENSG00000222041	CYTOR	1.03809856909957	0.0329515210214527	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0016642	integenic	Not conserved	hsa-miR-519d-5p,hsa-miR-1343-3p,hsa-miR-5787,hsa-miR-6779-5p,hsa-miR-6800-3p,hsa-miR-6813-5p	Mitochondrial heteroplasmy measurement,-	PLGLB2
ENSG00000286861	ENSG00000286861	-5.72004835430038	0.0329835613592591	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0102051	anti_sense	Not conserved			VTI1B
ENSG00000253930	TNFRSF10A-AS1	3.25701610860192	0.0331931270521901	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0150163	anti_sense	Not conserved			CHMP7
ENSG00000226332	ENSG00000226332	1.95009821250329	0.0342741121821823	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0131506	anti_sense	Not conserved		-	LAMA5
ENSG00000273230	ENSG00000273230	-2.07724036378339	0.0343609232452362	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0055653	integenic	Q50			INTS1
ENSG00000288908	ENSG00000288908	2.67771276706085	0.0344407107127202	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0137831	anti_sense	Q75			PQBP1
ENSG00000247134	ENSG00000247134	-1.74384536753339	0.0345863413862501	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0064447	integenic	Q50	hsa-miR-4441,hsa-miR-4463,hsa-miR-6069,hsa-miR-6803-5p	Airway imaging measurement,Protein measurement,-	NRG1
ENSG00000283696	ENSG00000283696	-2.21084280188029	0.0349091494869472	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0141946	integenic	Not conserved	hsa-miR-619-5p		SDHC
ENSG00000250508	LINC02701	-2.01501834720168	0.0363192997241042	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0085268	integenic	Not conserved	hsa-miR-619-5p		IGHMBP2
ENSG00000224995	LINC01526	-2.18686687745172	0.0376174145128046	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0051540	integenic	Q75	hsa-miR-761,hsa-miR-3619-5p,hsa-miR-6132	Loneliness measurement,Basophil count; Basophil percentage of leukocytes; Monocyte percentage of leukocytes,Coronary artery disease,Bmi-adjusted waist circumference,Cognitive function measurement,Body height,Myocardial infarction,Central corneal thickness,Intraocular pressure measurement,Adolescent idiopathic scoliosis,Bell's palsy,Bone density; Heel bone mineral density,Basophil count; Basophil percentage of leukocytes,Monocyte percentage of leukocytes,Central corneal thickness; Intraocular pressure measurement,Corneal resistance factor; Intraocular pressure measurement,Central corneal thickness; Corneal topography,Obsessive-compulsive disorder; Sex interaction measurement,Heel bone mineral density,-	TENT5A
ENSG00000267317	ENSG00000267317	-1.5504361460753	0.0383305026211045	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0123038	anti_sense	Q75	hsa-miR-6089	-	C19orf25
ENSG00000262001	DLGAP1-AS2	1.35052252890831	0.0400451900931874	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0119714	anti_sense	Q75	hsa-miR-619-5p,hsa-miR-4481,hsa-miR-4505,hsa-miR-1587,hsa-miR-6089,hsa-miR-7111-5p,hsa-miR-7150	Mean corpuscular volume,Mean reticulocyte volume,Blood urea nitrogen measurement; Serum urea measurement,Fat body mass,Mean reticulocyte volume; Mean corpuscular volume,Lip morphology measurement,Alanine measurement; Amino acid measurement,-	TGIF1
ENSG00000285813	ENSG00000285813	-5.72047378202056	0.0400609835759878	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0086900	anti_sense	Not conserved			GRIA4
ENSG00000234286	ENSG00000234286	-5.87598551595146	0.0400928458299928	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0149890	anti_sense	Q50			TRA2A
ENSG00000224616	RTCA-AS1	-1.7141839057383499	0.0402327977845685	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0005524	integenic	Not conserved	hsa-miR-4514	Lung carcinoma,-	DBT
ENSG00000234869	LINC02925	-2.73815499097377	0.0403020122640435	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0136023	integenic	Q50	hsa-miR-3620-5p,hsa-miR-1268b,hsa-miR-4437,hsa-miR-4505,hsa-miR-1587,hsa-miR-6131	Ocular sarcoidosis,Adolescent idiopathic scoliosis,-	GRAMD4
ENSG00000269934	ENSG00000269934	-3.15948098225582	0.0404260665523598	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0011224	anti_sense	Not conserved		-	TRIM11
ENSG00000287508	ENSG00000287508	-5.68873142329319	0.0413575515687856	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0106346	anti_sense	Q75	hsa-miR-1268b	Body height; Age at menarche; Puberty onset measurement,Annexin a2 measurement,Beta-secretase 1 measurement,Neuroticism measurement,Apolipoprotein a 1 measurement; Serum gamma-glutamyl transferase measurement; Serum albumin measurement,Balding measurement,Alopecia,C-reactive protein measurement; Serum gamma-glutamyl transferase measurement,C-reactive protein measurement; Bilirubin measurement; Serum gamma-glutamyl transferase measurement; Low density lipoprotein cholesterol measurement; Total blood protein measurement,C-reactive protein measurement,Serum alanine aminotransferase measurement; Birth weight; Serum gamma-glutamyl transferase measurement; Ykl40 measurement; Serum albumin measurement; Parental genotype effect measurement; Aspartate aminotransferase measurement,Calcium measurement,Erythrocyte count,Reticulocyte count,Age at menarche,Brain volume measurement,Tea consumption measurement; Cortical surface area measurement; Coffee consumption measurement; Triglyceride measurement; Cortical thickness,Serum alanine aminotransferase measurement; C-reactive protein measurement; Sex hormone-binding globulin measurement; Low density lipoprotein triglyceride measurement; Body mass index; Total cholesterol measurement; Body fat percentage; High density lipoprotein cholesterol measurement; Aspartate aminotransferase measurement,Sex hormone-binding globulin measurement; Mean corpuscular volume,Red blood cell density measurement,Serum gamma-glutamyl transferase measurement; Serum albumin measurement,Body mass index,Body height,Hematocrit; Hemoglobin measurement,Sex hormone-binding globulin measurement; Serum gamma-glutamyl transferase measurement,Hematocrit; Hemoglobin measurement; Erythrocyte count,-	FOXB1
ENSG00000267002	ENSG00000267002	-1.03841657199962	0.0413961935030376	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0116617	anti_sense,sense	Q90	hsa-miR-30b-3p,hsa-miR-6782-5p,hsa-miR-6803-5p	-	BRCA1
ENSG00000228506	PNISR-AS1	-1.20533121955797	0.0424542261149314	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0052183	anti_sense	Q50	hsa-miR-619-5p,hsa-miR-6807-3p,hsa-miR-8077	Response to ketamine,-	TSTD3
ENSG00000291176	ENSG00000291176	-3.66575752471977	0.042577874829493	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0017006	integenic	Q75			CIAO1
ENSG00000196810	CTBP1-DT	-1.00120515415641	0.0428402412438012	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0032263	anti_sense	Not conserved	hsa-miR-505-5p	Pulse pressure measurement,-	MAEA
ENSG00000236935	ENSG00000236935	-5.76869425763454	0.0430414453756616	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0084779	anti_sense	Q50	hsa-miR-920,hsa-miR-4302,hsa-miR-1268b,hsa-miR-4447,hsa-miR-4505,hsa-miR-6089	Body mass index,Psoriasis vulgaris; Sarcoidosis; Alopecia areata; Smoking initiation; Crohn's disease; Primary biliary cirrhosis,Non-melanoma skin carcinoma,Bmi-adjusted waist circumference,Bmi-adjusted waist circumference; Bmi-adjusted hip circumference; Bmi-adjusted waist-hip ratio,Hypothyroidism,Bmi-adjusted waist-hip ratio,Attention deficit hyperactivity disorder; Alopecia areata; Antisocial behaviour measurement; Substance abuse,Skin neoplasm; Thyroid preparation use measurement; Sarcoidosis; Non-melanoma skin carcinoma,Keratinocyte carcinoma; Leprosy; Sclerosing cholangitis; Basal cell carcinoma,-	TRMT112
ENSG00000266389	PIK3R5-DT	1.06544440627206	0.0436444538433128	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0114479	integenic	Q75	hsa-miR-4492,hsa-miR-6810-3p,hsa-miR-6845-5p		NTN1
ENSG00000232788	ITGA6-AS1	1.40139192486055	0.0441876166568916	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0020385	anti_sense	Q90	hsa-miR-320a-5p,hsa-miR-920,hsa-miR-6089,hsa-miR-6749-5p,hsa-miR-6784-5p,hsa-miR-6808-5p,hsa-miR-6846-5p	[pyruvate dehydrogenase acetyl-transferring] kinase isozyme 1, mitochondrial measurement,Eosinophil count,-	DLX2
ENSG00000287808	DHX9-AS1	-5.68851303957199	0.0449143441537561	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0008947	anti_sense	Q50	hsa-miR-619-5p	-	SHCBP1L
ENSG00000269044	ENSG00000269044	-1.2901827682736	0.0455696802626395	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0124458	sense	Not conserved	hsa-miR-665		SMIM7
ENSG00000285872	ENSG00000285872	-5.65629017010004	0.0456042424218084	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0012969	integenic	Q50	hsa-miR-4508,hsa-miR-6803-5p	-	ODC1
ENSG00000227477	STK4-DT	-5.76927635580615	0.0463806118386539	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0130354	anti_sense	Q50		Mean platelet volume,-	TOMM34
ENSG00000253395	LINC03044	-5.78554460031294	0.0471001458458886	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0067337	integenic	Q50	hsa-miR-619-5p,hsa-miR-4710,hsa-miR-6736-5p	Gut microbiome measurement,-	ZNF706
ENSG00000233559	LINC00513	3.99167118779473	0.0479286552059389	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0061393	integenic	Not conserved		Parental genotype effect measurement; Vitamin d measurement	MKLN1
ENSG00000291132	ENSG00000291132	-2.97681095538311	0.0480474457883016	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0002304	anti_sense	Q50	hsa-miR-6089	Intelligence,-	TMEM234
ENSG00000271976	ENSG00000271976	-1.36884735422932	0.0485404945273758	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0026254	anti_sense	Q75			ACTR8
ENSG00000273174	ENSG00000273174	1.21184199584695	0.0488031993306466	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0028857	anti_sense	Q50		-	GP9
ENSG00000222043	ENSG00000222043	2.50937646051381	0.049425609820712	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0020654	anti_sense	Q75	hsa-miR-326,hsa-miR-1237-5p,hsa-miR-6889-5p	-	HNRNPA3
ENSG00000246263	UBR5-DT	-1.68820010148563	0.0494449752550528	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0067415	anti_sense	Q90	hsa-miR-8485	-	ODF1
ENSG00000281491	DNAJB5-DT	5.64372195124774	0.0495601915307894	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0070885	anti_sense	Q75	hsa-miR-4652-5p,hsa-miR-4710,hsa-miR-6089	Response to quetiapine,Mean corpuscular volume; Mean corpuscular hemoglobin,Intelligence,-	VCP
ENSG00000249790	LINC02972	1.4105032443293	0.0499035917010816	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0089090	integenic	Not conserved			RIMKLB
ENSG00000286755	ENSG00000286755	5.62753530361175	0.049913369590124	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0032086	anti_sense	Q75	hsa-miR-6873-3p	-	IQCG
ENSG00000270020	ENSG00000270020	-6.25758420858804	0.0499158678260846	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0113307	integenic	Not conserved			MTHFSD
ENSG00000270001	ENSG00000270001	-5.63753216637787	0.0499520695507524	LPS_Whole_Cell_vs_Control_Whole_Cell	HSALNG0129272	sense	Not conserved	hsa-miR-211-3p,hsa-miR-4755-3p	Chronic kidney disease; Cystatin c measurement	CST3
